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Abstract 
 
 
 
All cells are separated from their environment by semipermeable membranes. This division 
demands the presence of systems with which cells can communicate with their 
surroundings. Integral membrane proteins carry out essential biological functions including 
signal transduction, metabolite and ion homeostasis and energy production. Secondary 
transporters are one kind of membrane protein that facilitate uptake of nutrients into a cell. 
Furthermore, they transport a vast number of drugs. Determining the structure of a 
biological macromolecule is a crucial step towards the understanding of its function and 
mode of operation. Very few X-ray structures of secondary transporters are available since 
crystallization of membrane proteins is a highly challenging endeavour. A novel approach 
to facilitating crystal growth is to enhance the thermal stability of a protein. Here, an easy 
and fast high-throughput screen was developed in order to identify thermostable variants of 
the Escherichia coli dipeptide transporter YdgR. In a first step, the screen distinguishes 
between active transporters and loss-of-function mutants. Second, the mutant transporter 
proteins are high-throughput purified, and their thermal stability is determined by static 
light scattering. Functional and structural studies on both the wildtype and mutant proteins 
should yield a more detailed insight into the mechanism of peptide transport. This 
promising strategy should be widely applicable to other proteins, and could be a very 
useful tool to boost the number of solved membrane protein structures. 
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Zusammenfassung 
 
 
 
Jede lebende Zelle ist von einer semipermeablen Membran umgeben, die sie von ihrer 
Umwelt abgrenzt. Diese Abgrenzung verlangt  das Vorhandensein von Systemen, durch 
die Zellen mit ihrer Umgebung kommunizieren können. Essentielle biologische 
Funktionen wie zum Beispiel Signaltransduktion, Metaboliten- und Ionenhomöostase und 
Energieproduktion werden von integralen Membranproteinen ausgeführt. Eine spezielle 
Art von Membranproteinen sind sogenannte sekundäre Transporter, die für die Aufnahme 
von Nährstoffen in die Zelle verantwortlich sind. Zusätzlich transportieren diese Proteine 
eine Vielzahl von Wirkstoffen. Ein wichtiger Schritt, um die Funktion und die 
Mechanismen eines biologischen Makromoleküls besser zu verstehen, ist die Aufklärung 
der Proteinstruktur. Da die Kristallisation von Membranproteinen sehr anspruchsvoll und 
mühsam ist, gibt es nur sehr wenige Röntgenstrukturen von sekundären Transportern. Eine 
neuartige Verfahrensweise, in der die thermische Stabilität eines Proteins erhöht wird, 
erleichtert die Kristallisation. In diesem Projekt wurde ein einfacher und schneller „high-
throughput“ Screen entwickelt, um thermostabilere Mutanten des Escherichia coli 
Dipeptidtransporters YdgR zu identifizieren. Der Screen selbst besteht aus zwei Schritten. 
Der erste trennt funktionelle Transportermutanten von inaktiven Mutanten, im zweiten 
Schritt werden die mutierten Proteine aufgereinigt, und deren Stabilität wird mittels static 
light scattering (statische Lichtstreuung) bestimmt. Funktionale und strukturelle Studien an 
Wildtyp- und Mutantenproteinen sollen einen detailierteren Einblick in den Mechanismus 
des Peptidtransports geben. Die hier entwickelte Strategie ist ein vielversprechendes 
Werkzeug, welches auch an anderen Proteinen anwendbar ist, und somit helfen könnte, die 
Anzahl an gelösten Membranproteinstrukturen zu erweitern. 
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1. Introduction 
 
 
 
A cell is surrounded by a semipermeable membrane, which separates it from the 
environment. Furthermore, in eukaryotic cells membranes also divide a cell into different 
compartments. Each compartment serves various different purposes. This 
compartmentalization has a number of advantages, for example, the enrichment of certain 
compounds such as enzymes or ions, or the partitioning of metabolic reactions. However, 
dividing a cell into different compartments demands the presence of a system that can 
shuttle compounds such as substrates, metabolites or catalysts from one compartment to 
another. Small hydrophobic molecules can penetrate the membrane but hydrophilic 
compounds must be transported. For this purpose, cells have evolved membrane channels 
and transport proteins. Both types are integral membrane proteins that allow for the 
passage of different molecules. The difference between these types of proteins is basically 
the mechanism of transport. Channels can either be constantly open or shuttle between an 
open and a closed state. The transport itself, however, is passive. The transported substrate 
diffuses across the membrane down its concentration gradient. In contrast to channel 
proteins, transporters translocate a substrate actively. This means that compounds can be 
transported against their concentration gradient at a certain energy expense. Transporters 
are divided into primary and secondary active transporters and a smaller third group, 
according to their mode of transport. Primary transporters such as P-type ATPases and 
ATP-binding cassette (ABC) transporters use energy generated by ATP hydrolysis to 
translocate their substrate. Secondary transporters, however, couple the translocation of 
their substrates to the movement of other molecules down their concentration gradient. 
This movement is energetically favourable and hence drives the active transport. A third 
class of transporters couple the transport to an energetically favourable chemical 
modification of the respective substrate (Law et al., 2008, Locher et al.2003). Transporters 
can either function as uniporters, symporters or antiporters. Uniporters transport one 
substrate using the energy stored in the substrate gradient. Symporters and antiporters 
translocate two or more substrates across the membrane at the same time; the latter 
transports two substrates in opposite directions. Both are energized by the electrochemical 
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gradient. The lactose permease LacY is an example of a symporter. A lactose molecule is 
imported with the concomitant transport of a proton. In contrast, GlpT, the glycerol-3-
phosphate transporter, is an antiporter. Upon substrate import, inorganic phosphate is 
exported (Fig. 1A). 
 
 
 
1.1. Alternating access model of transport 
 
The largest group among secondary transporters is the major facilitator superfamily (MFS). 
This family has a vast variety of substrates, ranging from peptides, nucleotides and sugars 
to ions. Most of the MFS family members are predicted to have twelve transmembrane 
helices, and are thought to function as monomers. The N- and C-termini are located on the 
cytoplasmic side. There are a few exceptions, where family members have 14, 24 or 6 
membrane spanning domains. The latter most likely functions as a homodimer (Wang et 
al., 2008). Most transporter structures are of MFS family members or members of closely 
related families such as the benzyl-hydantoin transporter Mhp1 (Weyand et al., 2008), 
which belongs to the nucleobase cation symport-1 family (NCS-1), or the sodium 
glucose/galactose transporter vSGLT (Faham et al., 2008), a family member of the solute 
sodium symporters (SSS) or the leucine transporter LeuT (Yamashita et al., 2005, Singh et 
al. 2008), a member of the neurotransmitter sodium symporters (NSS). 
A general model describing the mode of action of secondary transporters is the alternating 
access model (Widdas, 1952, Jardetzky, 1966). The transporter undergoes conformational 
changes resulting in alternating access to the ligand binding site (Fig.1A). The protein is 
open to one side of the environment at a time, for example, either to the extracellular or to 
the intracellular space. The model is supported by all secondary transporter structures 
solved to date. However, transport proteins can not only occupy an inward-facing (Ci) and 
an outward facing (Co) conformation, but also an occluded state where the substrate 
binding site is not accessible from either side (Yamashita et al., 2005, Yin et al., 2006). 
There are no structures of secondary transporters from mammals so far since high 
expression levels are extremely difficult to reach. It is thought that alternating access can 
be accomplished by two different mechanisms, referred to as the rocker-switch and the 
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alternating gate. In contrast to the rocker-switch model, the alternating gate or gated pore is 
a more channel-like protein that has a gate on each side, which open in an alternating 
mode. A transporter working with a rocker-switch mechanism moves both halves of the 
protein (Fig. 1B), and undergoes a more extensive conformational change than its 
counterpart (Karpowich et al., 2008).  
 
 
 
Figure 1. The alternating access model of transport. 1 (A)The lactose permease LacY is a 
symporter dependent on the proton gradient. The glycerol-3-phosphate transporter GlpT works in 
an antiport mechanism. Upon glycerol-3-phosphate uptake, inorganic phosphate (Pi) is exported. 
The transporters are accessible only from one side of the membrane at a time. They undergo a 
conformational change that is thought to translocate the substrate to the other side. (B) The 
alternating access model allows two mechanistic possibilities: the rocker-switch and the gated pore. 
LacY and GlpT (A) work in a rocker switch mode. The two halves of the protein undergo a 
conformational change, which makes the substrate binding site either accessible to the cytoplasmic 
or the extracellular side. In the gated pore or alternating gate, the quasi channel-like protein 
possesses a gate at each side of the pore. Through a small conformational change, these gates 
alternately open and close. According to Karpowich et al., vSGLT, the galactose transporter, is an 
example of an alternating gate. 
 
                                                 
1 Figure adapted from Locher et al., 2003 
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Others disagree with this strict separation. The idea is rather that all MFS family members 
function in the same way as indicated by all structures solved so far. A small gate, i.e. a 
single amino acid or short part of a helix, serving as a primary gating element, excludes the 
substrate from the environment. In a second step that involves larger conformational 
rearrangement of transmembrane domains (TMDs), the substrate is translocated across the 
membrane, leading to inward- or outward facing cavities (Diallinas, 2008) (Fig. 2). 
 
 
Figure 2. Conformational changes in MFS family members upon substrate uptake.2 Upon 
substrate (black hexagon) binding, extracellular gating elements (red) exclude it from the 
environment (A, B). A larger conformational movement of helices (B to C, green and turquoise) 
switches the transporter from an outward- to an inward-facing conformation, where the substrate 
can be finally released (opening o the intracellular gate (yellow)).  
 
 
Most secondary transporter structures have been solved in an inward-facing conformation, 
for example the structures of the glucose/galactose transporter from Vibrio 
parahaemolyticus, vSGLT (Faham et al., 2008) or the Escherichia coli glycerol-3-
phosphate transporter GlpT (Huang et al., 2003) and lactose permease LacY (Abramson et 
al., 2003). One transporter crystallized not only in an outward-facing conformation but also 
in the substrate-bound occluded state is the benzyl-hydantoin transporter Mhp1 from 
Microbacterium liquefaciens (Weyand et al., 2008). Although the allocation of the diverse 
helices is different in the respective transporters, they all display a similar architecture. 
Using LacY as an example, they are comprised of two parallel repeats (Mhp1 and vSGLT, 
for example, contain inverted repeats instead) and intra- or extracellular cavities as shown 
in Figure 3A, through which the substrate can access the binding site. Furthermore, they 
possess kinked or broken helices, which are located at the central part of the transporter 
                                                 
2 Figure taken from Diallinas, 2008 
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close to the substrate binding site. Because of these similarities, structures representing 
most steps in the transport cycle are now available. 
 
A 
 
B 
Figure 3. Overall structure of LacY. 3 The figures are based on the C154G mutant structure with 
a bound substrate homolog, TDG (β-D-galactopyranosyl-1-thio-β-D-galactopyranoside). (A) 
Ribbon representation of LacY viewed parallel to the membrane. The 12 transmembrane helices 
are colored from the N-terminus in purple to the C-terminus in pink; TDG is represented by black 
spheres. (B) Secondary structure schematic of LacY. The N- and C-terminal domains of the 
transporter are colored blue and red, respectively. Residues at the kinks in the transmembrane 
helices are marked with purple rectangles; residues marked with green and yellow circles are 
involved in substrate binding and proton translocation, respectively; residue Glu269, represented 
by a light blue circle, is involved in both substrate binding and proton transfer. The hydrophilic 
cavity is designated by a light blue triangle, and TDG is shown as two black circles; h1 to h4 
denote surface helices. 
 
                                                 
3 Figure plus legend taken from Abramson et al., 2003 
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1.2. The POT family of transport proteins 
 
 
As already mentioned, cells need to take up nutrients from their environment in order to 
survive. Amino acids, for example, are taken up by a class of peptide transporters, the 
proton oligopeptide transporters (POT) (Paulsen et al. 1994), in the form of short peptides 
(Daniel et al., 2006). These transporters are conserved among almost all species, from 
humans to bacteria. Comparing family members throughout species reveals three strikingly 
conserved regions. The first of these so-called PTR motifs (Peptide Transporters) on 
transmembrane domain 1 is followed by a second motif comprising parts of TMD 2 and 3 
plus their interjacent loop. The third motif, in helix 5, the FYING-PTR motif, is the most 
conserved among all species (Table 1). 
 
Table 1. Alignment of conserved motifs of the SLC15 peptide transporter family. 
 Motif 1 PTR 2-1 motif  FYING-PTR motif 
     *EF*ERF*YYG*     G***AD***GK**TI***S**Y**G      *FS*FY*AIN*GSL* 
H..sapiens PEPT 22NEFCERFSYYGM 69GALIADSWLGKFKTIVSLSIVYTTG 162FFSIFYLAINAGSLL 
C. elegans PEP1  55NEFCERFSYYGM 102GSIVADGYIGKFWTIFSVSILYAIG 184FFSMFYFAINAGSLI 
S..cerevisiae Ptr2  88VELSERFSYYGL 44GGYVADTFWGKYNTICCGTAIYIAG 143VFMIFYLAINVGSLS 
L. lactis DtpT  24TEFWERFSYYGM 78GGWVADRLLGASRTIFLGGILITLG 152GFNIFYLAINMGSLI 
E. coli YdgR  22IELWERFGYYGM 77GGWLGDKVLGTKRVIMLGAIVLAIG 151AFSIFYLAVNIGSFF 
 
 
Humans possess four members of this family, two of which are well characterized, the 
peptide transporters PEPT1 (SLC15A1), and PEPT2 (SLC15A2). PEPT1, the low-affinity, 
high-capacity transporter, is mainly expressed in brush border membranes of the small 
intestines. PEPT2, which has a high affinity but a low capacity, is expressed in the lung, 
and both are expressed as a renal isoform (Weitz et al., 2007). Although Na+ driven 
transport processes are relatively more frequent in mammals, these peptide transporters use 
the proton gradient as a driving force, and are therefore also called “archaic” transporters 
(Daniel et al., 2006). PEPT1 and PEPT2 possess a large number of possible substrates, 
which include essentially 400 or 8000 possible dipeptides or tripeptides, respectively. 
Furthermore, they transport β-lactam antibiotics, which represent a broad class of penicillin 
derivatives, and also other therapeutic drugs such as angiotensin-converting enzyme 
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inhibitors (ACE inhibitors). More interesting, the substrate does not require a peptide bond 
for recognition by the mammalian PEPTs (Doring et al., 1998).  There is no crystal 
structure available, but topological studies suggest 12 transmembrane domains. (Covitz et 
al., 1998). Salmonella typhimurium harbours three different oligopeptide transport systems, 
the oligopeptide permease OppA and the dipeptide permease DppA, which are ABC 
transporters. The third one is a tripeptide permease system, which members belong to the 
described POT family. The only characterized representative is called tppB (tripeptide 
permease B). The respective homologue identified in Escherichia coli is called YdgR (or 
sometimes also E. coli tppB or DtpA). YdgR was described as a dipeptide and tripeptide 
transporter, which could also transport various other substrates (Weitz et al., 2007). 
However, there is also no structural data available. It is not determined yet whether the E. 
coli protein also has twelve membrane spanning domains as its human homologue, or 
fourteen as suggested by prediction programs. The family contains three other members 
homologous to the S. typhimurium proteins. YhiP is a di- and tripeptide transporter as well 
(Harder et al., 2008), and YbgH and YjdL are two poorly characterized proteins. YdgR 
was identified as a target regulated by the EnvZ/OmpR two-component regulatory system 
(Goh et al., 2004). EnvZ is an integral membrane protein kinase, which phosphorylates its 
response regulator OmpR upon environmental stress. Similar to its family members, 
transport activity of YdgR was demonstrated to be proton-dependent (Weitz et al., 2007). 
Substrate specificity assays showed that the transporter prefers di- and tripeptides in their 
L-stereomeric form. Also, YdgR transports peptidomimetics such as β-lactam antibiotics 
and ACE inhibitors.  
It would be very important to understand the structural features and exact mechanisms of 
transport of this family, since a large number of drugs and antibiotics are transported by 
this family. Furthermore, certain drugs can be coupled to amino acids and thereby become 
a substrate for these transporters. The working effect of a drug is often diminished because 
of its low bioavailability, i.e. that it cannot be taken up into cells. A structure of a POT 
would be useful because a drug could then be designed in a way so that it is taken up by a 
certain transporter or in a certain tissue where it is needed. 
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1.3. X-ray crystallography 
 
Determining the structure of a biological macromolecule is a very important step towards 
understanding its function and mode of operation. One method of doing so is structure 
determination by X-ray crystallography. Not only inorganic materials such as salts or 
metals can form crystals but also organic macromolecules. Highly purified protein forms 
crystals under certain conditions. These crystals are then subjected to X-rays, and the 
scattered electrons produce a three-dimensional electron density map, from which the 
positions of the respective atoms, amino acids and their side chains, can be determined. In 
contrast to other structure determination methods such as electron microscopy, for 
example, X-ray structures with a very high resolution can be obtained. Crystallization 
itself, however, is a challenging task. Protein contacts in the crystal are influenced by pH, 
ionic strength and the presence or absence of ions in the solution. In principle, the optimal 
crystal growing conditions have to be found empirically.  
Crystallizing an integral membrane protein is even more demanding. Therefore, structural 
information is relatively sparse, although approximately 20 to 30 % of most genomes 
encode for membrane proteins. First, the respective protein has to be produced and purified 
in milligram amounts. This can often be very difficult because overexpression in the 
membrane tends to be toxic for the cells, or the expression leads to formation of aggregates 
or inclusion bodies. It is possible to solubilize these aggregates using high concentrations 
of chaotropes, such as guanidinium chloride or urea, but also SDS or alkaline pH. 
However, these solubilized proteins are often inactive. A second major problem arises 
when trying to crystallize a membrane protein. Integral membrane proteins are surrounded 
by lipids in the lipid bilayer, and are generally very hydrophobic. When a membrane 
protein is purified from its native environment, the hydrophobic surfaces tend to cluster to 
protect themselves from a hydrophilic environment, and the protein aggregates. To 
overcome this problem, these proteins have to be purified either in an organic solvent or 
solubilized in an aqueous solvent containing detergent. The latter is done more frequently 
because organic solvents often render a protein inactive. A detergent is an amphiphilic 
molecule consisting of a hydrophobic tail group and an amphiphilic head (Fig. 4B, left), 
which forms a micelle above a certain concentration, also called the critical micelle 
concentration (cmc). When a hydrophobic protein is present, detergent molecules adsorb 
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around the hydrophobic transmembrane helices, thereby replacing the lipid bilayer (Fig. 
4B, right). There are hundreds of different detergents with various combinations of head 
and tail groups, and they differ greatly in their structures and solubilizing power. Three 
widely used examples are depicted in Figure 4A, sodium dodecyl sulfate (SDS), 
octoxynol-9 (Triton X-100) and β-D-octylglucoside (β-D-OG). SDS is a rather aggressive 
detergent, whereas β-D-OG is milder, and frequently used for crystallization. 
 
 
B A 
Figure 4. Detergents. (A)4 Structural representation of three common detergents. The uppermost 
compound is one of the most widely used detergents, sodium dodecyl sulfate (SDS). Triton X-100, 
also called octoxynol-9 (middle) and β-D-octylglucoside (undermost) are milder detergents. (B)5 
Schematic representation of a detergent molecule with its polar head group (pink) and a 
hydrophobic tail (green) forming a micelle (left panel). Membrane proteins are embedded in the 
lipid bilayer. Upon addition of detergent, they are present in a solubilized form (right panel). 
 
 
 
The lipid bilayer surrounding an integral membrane protein is usually quite complex in its 
composition, depending on the organism as well as the compartment. Replacing it by a 
detergent is therefore only a crude substitution, and can disturb intra-protein interactions or 
                                                 
4 Figure taken from http://pubchem.ncbi.nlm.nih.gov/ 
5 Figure adapted from Stryer, L. Biochemistry. W H Freeman 
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render a protein inactive. So far it is not possible to predict the optimal detergent for a 
respective protein, but rather it has to be determined empirically. However, having 
identified an optimal detergent for purification does not mean that it is also ideal for other 
purposes. Certain detergents solubilize a protein very well, but render it unstable. Others 
are relatively mild detergents, and stabilize the protein, but seem to disturb crystallization. 
More aggressive, shorter chain length detergents are better for crystallization, but can also 
damage protein integrity. 
Until now (until January 2009), approximately 10 crystal structures of secondary 
transporters have been solved. They have provided many valuable insights into the 
mechanisms of transport. They all support the alternating access model of transport. As 
already mentioned, some of them work as a rocker-switch and some rather as an 
alternating gate. However, many questions still remain unanswered. Furthermore, in order 
to understand the exact mechanism of transport, modelling the protein based on one of the 
available structures is simply often not enough to yield satisfying results since it is only a 
model based on a different protein. Therefore, a method to enhance crystallization of 
membrane proteins would be gladly welcomed.  
 
 
1.4. Protein thermostability  
 
As already mentioned, protein crystallization is screened in various buffers, detergents and 
additives in order to yield ordered, highly diffracting crystals. Often, a vast number of 
proteins from different organisms are tested for high expression levels and enhanced 
stability. An observation made over the years, is that the more thermostable a protein is the 
more readily it crystallizes. Therefore, homologues from thermophiles are often good a 
choice. 
A different approach is to make a protein more stable by mutagenesis. Engineering of 
proteins can, of course, have other purposes than enhancing thermostability, for example 
altering the specificity of an enzyme, boosting the enzymatic activity or enhancing 
overexpression (Martinez Molina et al., 2008). There are certain criteria that make a 
protein more thermostable. These features were found when comparing proteins from 
mesophilic and thermophilic organisms. In order to maintain protein integrity at higher 
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temperatures, thermophiles need to possess proteins with higher stability. These strategies 
include ionic interactions, hydrophobic interactions and π stacking, covalent bonds in 
disulfide bridges or post-translational modifications, such as lysyl-methylations. Also, a 
high ratio of charged to uncharged amino acids, especially on the protein surface, 
contributes to thermal stability, probably due to an increase in ionic interactions. 
Thermophiles often possess a higher CG content in their coding sequences, which favours 
the presence of certain amino acids. Other amino acids such as methionine or asparagine 
are less abundant because they are not stable at higher temperatures. (Trivedi et al., 2006). 
However, theses strategies cannot be generalized. Thermophiles and hyperthermophiles 
use different strategies and combinations of these, rendering their proteins more 
thermostable. It is hence not yet possible to predict the thermostability of a protein, or add 
certain features to increase it. Also, it seems that many attributes accounting for 
thermostability in soluble proteins do not necessarily translate to membrane proteins. A 
general characteristic of integral membrane proteins is their modest stability, which can 
lead to rapid unfolding and inactivation. It was calculated that approximately 10 % of 
random mutations improved the stability of a membrane protein (Bowie, 2001; Zhou et al., 
2000). This might not be true for all membrane proteins, but when comparing this to 
soluble proteins, a much lower percentage of mutations increased stability. Thus, it seems 
that possible stabilizing interactions in membrane proteins have not been selected for by 
evolution. Being optimized to its lipid environment, lower stability and therefore higher 
flexibility might be necessary for optimal protein function, especially in transporters, 
which have to undergo large conformational changes across the membrane.  
Some of the known membrane protein crystal structures are of proteins from thermophiles. 
The Na+/Cl- dependent leucine transporter, LeuT, for example, was purified and 
crystallized from the thermophile Aquifex aeolicus (Yamashita et al., 2005, Singh et al. 
2008). Recently, the structure of the β1-adrenergic receptor (Serrano-Vega et al., 2008) has 
been solved using mutagenesis as a tool for conformational thermostabilization. This G-
protein coupled receptor (GPCR) was subjected to alanine-scanning mutagenesis. This 
method is simple but also labour-intensive. Every residue in the protein is individually 
mutated to an alanine. Six combined point mutations in the β1-adrenergic receptor (β-AR) 
enhanced the melting temperature by 21°C. The same approach was applied to another 
GPCR, the human adenosine A2a receptor. There is no crystal structure of this mutant yet, 
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but different mutations increased the thermal stability by 17°C in the antagonist bound 
form and 9°C in the agonist bound form, respectively (Magnani et al., 2008). 
Similarly, the structure of the lactose permease LacY was solved using a thermostable 
cysteine mutant for crystallization (Abramson et al., 2003). The reason why enhanced 
thermostability facilitates crystallization is not really known. A fact, however, is that 
transporters are quite dynamic and flexible proteins. This might be disadvantageous for 
crystal formation since a crystal is a highly ordered structure.  It is thought that certain 
mutations arrest the transporter in one conformation of the transport cycle, thereby 
prohibiting movement and leading to a more rigid structure and decreased flexibility. 
Therefore, the protein might be more thermostable. Indeed, it was demonstrated that the 
LacY mutant is locked in an inward-facing conformation (Smirnova et al., 2003).  
 
 
1.5. Outline of the diploma project 
 
The main aim of this diploma project was to establish an easy and efficient screen to 
identify thermostable mutants of the Escherichia coli dipeptide transporter YdgR. This 
screen consists of two steps: one to first distinguish between active transporters and loss-
of-function mutants, and a second step to measure their thermostability. To accomplish 
this, a library of transporter mutants had to be generated, and two assays had to be 
established and optimised. The first one is a growth assay, by which mutant proteins that 
retain transport activity are separated from the non-transporters. Second, a high throughput 
purification and thermostability assay had to be established. Furthermore, several loss-of-
function mutants were biochemically characterized. 
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2. Materials and Methods 
 
 
 
2.1. Materials 
 
The chemical compounds listed here were purchased either from Fluka or Sigma, the 
enzymes and protein ladders from Fermentas if not stated otherwise. 
 
2.1.1.General Media, Solutions, Reagents and Enzymes 
 
2.1.1.1. Media 
LB-medium: Luria-Bertani medium  
10 g tryptone, 5 g yeast extract, 10 g NaCl in 1 L dH2O (deionized 
water), pH 7, autoclaved  
SOB:  Super-Optimal broth6
20 g tryptone, 5 g yeast extract, 0.5 g NaCl, 2.5 mM KCl in 1 L dH2O, 
autoclaved 
SOC: Super-Optimal catabolite repression 
 SOB containing 2 % glucose 
SOC salt: SOC containing 25 mM magnesium salt (12.5 mM MgCl2, 12.5 mM 
MgSO4) 
SOB CC:  SOB for competent cells 
20 g tryptone, 5 g yeast extract, 0.5 g NaCl, 2.5 mM KCl in 1 L dH2O, 
autoclaved, 10 mM sterile MgCl2
 
2.1.1.2. Chemical compounds 
APS: ammonium peroxodisulfate  
 10 % (w/v) solution in dH2O, sterile-filtered, stored at -20°C 
 
                                                 
6 According to Doug Hanahan - the author of "J. Mol. Biol. 166(4): 557-580", where SOB was first 
described. 
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IPTG: isopropyl β-D-1-thiogalactopyranoside 
 0.5 M stock solution in dH2O, sterile-filtered, stored at -20°C 
DTT: dithiothreitol   
 1 M stock solution in dH2O, sterile-filtered, stored at   -20°C 
EDTA: ethylenediaminetetraacetic acid 
 0.5 M stock, pH 8 
Ala-Ala: H-Ala-Ala-OH (alanyl-alanine)  
 1 M stock solution in dH2O, prepared freshly or stored at -20°C 
β-Ala-Lys-AMCA:  N-7-amino-4-methylcoumarin-3-acetic acid labeled alanyl-lysine  
 5 mM stock in DMSO, stored at -80°C 
 
2.1.1.3. Detergents 
SDS: sodium-dodecyl sulfate 
 10 % stock in dH2O 
DDM: n-dodecyl-β-D-maltoside, Anatrace 
cmc (H2O) ~ 0.17 mM (0.0087 %), micelle size: 72 kDa, prepared 
freshly as  10 % stock 
FOS-12 n-dodecylphosphocholine (foscholine-12), Anatrace  
 cmc (H2O) ~ 1.5 mM (0.047 %), prepared freshly as 10 % stock 
 
2.1.1.4. Enzymes 
Lysozyme:  50 mg/ml solution in dH2O, stored at -20°C 
 
2.1.1.5. Antibiotics 
Ampicillin:  100 mg/ml stock solution in dH2O, sterile-filtered, stored at -20°C, 
used as a 1:1000 dilution  
Carbenicillin:  50 mg/ml stock solution in dH2O or 50% glycerol/dH2O, sterile-
filtered, stored at -20°C, used as a 1:1000 dilution  
Kanamycin:  50 mg/ml stock solution in dH2O, sterile-filtered, stored at -20°C, used 
as a 1:1000 dilution  
Alafosfalin:  L-alanyl-L-1-aminoethylphosphonic acid 
 1 M stock in dH2O 
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2.1.1.6. Buffers 
5x SDS LB: 5x SDS loading buffer 
62.5 mM Tris pH 8, 10 % (v/v) glycerol, 2 % (w/v) SDS, in dH2O, 
Bromophenol Blue (tip of a spatula for approximately 40 ml), stored 
at room temperature, 50 µl of β-mercaptoethanol added freshly to 950 
µl of solution 
1x SDS RB: 1x SDS running buffer:  
25 mM Tris/HCl pH 8.3, 200 mM glycine, 0.1 % (w/v) SDS, prepared 
as 5x stock, stored at 4°C 
10x TAE buffer:  Tris/acetate/EDTA 
 0.4 M Tris/HCl pH 8, 10 mM EDTA-Na2-salt, 0.2 M acetic acid 
6x DNA LD:  6x DNA loading dye 
0.25 % (w/v) Bromophenol Blue, 50 % (w/v) sucrose in dH2O, stored 
at 4°C 
1x TB: Tris buffer, Western blot transfer buffer 
25 mM Tris/HCl pH 8, 192 mM glycine, 10 % methanol; prepared as 
10x stock without methanol, stored at 4°C  
1x TBS:  tris buffered saline 
10 mM Tris/HCl pH 8, 150 mM NaCl, prepared as 10x stock, stored at 
4°C 
1x TBS-T: TBS Tween 
 0.1 % Tween-20 added to 1x TBS, stored at 4°C   
Inoue-buffer:  10 mM HEPES pH 6.7, 250 mM KCl, 15 mM CaCl2*2 H2O,   55 mM  
MnCl2*4 H2O 
Krebs-buffer:  modified: 25 mM Tris pH 7.5, 140 mM NaCl, 5.4 mM KCl, 1.8 mM 
CaCl2, 0.8 mM MgSO4, 0.09 % glucose, in dH2O, sterile-filtered, 
stored at 4°C 
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2.1.2. Bacterial strains 
 
Bacterial strains used in these experiments are given in Table 2.  
 
Table 2. Bacterial strains with respective genotypes. 
Bacterial strain Genotype Description 
DH5α E. coli F-φ80dlacZ∆M15 
∆(lacZYA-argF)U169 deoR, 
recA1 endA1 hsdR17(rk- mk+ 
phoA supE44λ- thi-1 gyrA96 
relA1 
DH5α cells are widely used for 
simple and efficient DNA 
transformation and preparation.  
BL21(DE3) 
Stratagene 
E. coli B F– dcm ompT 
hsdS(rB– mB–) gal λ(DE3) 
 
The BL21 strain carries a 
chromosomal copy of the T7 
promoter. It provides high-level 
protein expression, but has the 
potential risk of leaky expression.  
BL21 
Gold(DE3) 
pLysS 
Stratagene 
E. coli B F– ompT hsdS(rB– 
mB–) dcm+ Tetr gal λ(DE3) 
endA Hte [pLysS Camr] 
These cells provide a tighter control 
due to the expression of T7 
lysozyme (T7 RNA polymerase 
inhibitor) 
C43(DE3) 
 
Strain derived from C41 (DE3), 
which in turn is derived from 
BL21(DE3) 
This strain carries an undefined 
mutation that allows for the 
overexpression of otherwise toxic 
proteins i.e. integral membrane 
proteins (Walker et al., 1996). 
JW1626 
 
E. coli K12 BW25113 dYdgR,  
rrnB3 #lacZ4787 hsdR514 
#(araBAD)567 #(rhaBAD)568 
rph-1 
YdgR knock-out strain, Keio-
collection (single-gene deletions of 
3985 non-essential E. coli K12 
genes) (Baba et al., 2005). 
XL10-Gold 
Stratagene 
E. coli TetrD(mcrA)183 
D(mcrCB-hsdSMR-mrr)173 
endA1 supE44 thi-1 recA1 
The cells provide enhanced 
transformation efficiency and are 
therefore extremely useful when 
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gyrA96 relA1 lac Hte [F´ 
proAB lacIqZDM15 
Tn10 (Tetr) Amy Camr 
generating plasmid DNA libraries 
(larger, more complex libraries).  
Fusion-Blue 
Clontech 
E. coli K-12 endA1, hsdR17 
(rK12-,mK12+), supE44, thi-1, 
recA1, gyrA96, relA1, lac 
F'[proA+B+, 
lacIqZ∆M15::Tn10(tetR)] 
High transformation efficiency with 
an additional blue-white screening 
capability (when using a plasmid 
that provides α-complementation). 
 
 
2.1.3. Plasmids 
 
A pCS19 vector (derived from pQE (Ehrmann et al. 1999), Fig. 5), a pET vector 
(Novagen) and a pJET vector (GeneJET Cloning Kit, Fermentas) were used for all cloning 
and expression experiments conducted here. 
 
Figure 5. Schematic representation of the pCS19 vector. The vector carries an ampicillin 
resistance gene, and has a YdgR gene with a C-terminal His-tag inserted in its multiple cloning site 
(MCS). 
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2.2. Methods 
 
2.2.1. Molecular cloning techniques 
 
2.2.1.1. Agarose gel electrophoresis 
Agarose gel electrophoresis separates DNA molecules according to their size. PCR or 
restriction fragments as well as purified plasmids were analyzed on 1 % or 2 % agarose 
gels depending on the size of the fragment. Agarose was dissolved in 1x TAE buffer by 
heating it in the microwave. SYBR Safe DNA gel stain (Invitrogen) was added to visualize 
separated DNA bands. 
 
2.2.1.2. DNA gel extraction and PCR purification 
DNA was purified using either the QIAquick gel extraction or PCR purification kit 
(Qiagen), according to the provided protocol using an Eppendorf microcentrifuge. The 
purified DNA was eluted in either 30 or 50 µl of dH2O. 
 
2.2.1.3. Restriction digest and ligation 
DNA restriction digests were performed overnight in a 50 µl reaction mixture containing 
1x buffer (according to enzyme requirements or Fermentas double digest function:  
http://www.fermentas.com/ doubledigest/index.html), 0.1 U/µl enzyme, alkaline 
phosphatase (only when cutting vector) and 2-5 µg DNA. In order to verify a vector insert 
by restriction, fast digest enzymes were used according to protocol. Vector and insert were 
ligated for two hours with T4 ligase in ligation buffer in a 5x molar excess of the insert. 
The ligation mixture was directly transformed into competent E. coli.  
 
2.2.1.4. Generation of competent E .coli cells 
BL21(DE3) and XL-10 gold competent E. coli cells were made according to the Inoue-
protocol7. Purchased competent cells from a -80°C stock were thawed, shaken in SOC for 
30 minutes and plated on an LB plate. A single colony was picked, inoculated into 25 ml 
SOB (see “SOB for competent cells” for recipe) in a 100 ml flask and grown for seven 
hours at 37°C at 250 rpm. 10, 4 and 2 ml were inoculated in 250 ml SOB in a 1 L flask and 
                                                 
7 from Sambrook J., Molecular Cloning, 3rd Edition (2001), Cold Spring Harbour Laboratory Press 
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were incubated at 18 °C overnight at 190 rpm. The cells were grown to an OD600 of 0.6 
and incubated in an ice-water bath for 10 minutes. The cultures were pelleted at 2500 g for 
10 minutes at 4°C. The pellet was dried, washed in 80 ml of ice-cold Inoue-buffer, and 
resuspended in 20 ml of Inoue buffer. 1.5 ml of DMSO were added and the suspension was 
aliquoted and immediately frozen in liquid nitrogen and stored at -80°C. 
 
2.2.1.5. Transformation of competent E. coli 
Fifty nanograms of plasmid DNA were transformed into 50-100 µl of E. coli competent 
cells. The cells were incubated with the DNA for 15 minutes on ice, then heat-shocked for 
1 minute at 37°C, and cooled on ice for a further two minutes. 500 µl SOC medium were 
added and the cells were incubated with shaking at 37°C. The transformed bacteria were 
plated onto LB plates containing the respective antibiotics. The transformation for In-
Fusion as well as library cloning were performed in Fusion-Blue or XL-10 Gold competent 
cells delivered with the respective kits according to provided transformation protocols. 
 
2.2.1.6. Random mutagenesis 
Random mutagenesis of a gene can be a useful tool to establish a library of clones with 
improved or altered features. Such a desired characteristic is for example loss or gain-of-
function, increased thermostability or enhanced production of a protein. In principle, the 
infidelity of a DNA polymerase is exploited to introduce mutations randomly. The 
mutation rate depends primarily on the error rate of the polymerase, but can further be 
influenced by varying the concentration ratios of components in the PCR reaction.  
Here, I introduced random mutations into distinct regions of the YdgR gene by using the 
GeneMorph II Random Mutagenesis Kit (Stratagene). First, the gene fragment of interest 
was amplified using the provided, error-prone polymerase (Mutazyme II). The purified 
target fragment then served as a so-called “megaprimer” in a second PCR reaction, in 
which the whole target plasmid was amplified. The parental DNA plasmids were digested 
with the DpnI restriction enzyme, which targets methylated and hemi-methylated DNA, 
leaving the new plasmids containing the desired mutations intact (Fig. 6).  
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Figure 6. Principle of GeneMorph (Stratagene) random mutagenesis. A targeted gene region is 
randomly mutated exploiting the infidelity of a Taq polymerase mixture (Mutazyme II, Stratagene). 
The mutagenized fragment is used as a megaprimer to amplify a template plasmid. After this PCR 
reaction the parental plasmid is digested by a DpnI digest, leaving a mutated plasmid library. 
 
 
 
I introduced random mutations into 4 different regions of the YdgR gene, i.e. helix 6 and 
helix 7, Helix 8 and 9, and Helix 11 and all of their adjacent loops (Fig. 7). Particular 
regions were left out, for example Helix 1 and Helix 5, which contain rather conserved 
regions and thus mutations would probably lead to more severe phenotypes, such as 
misfolding or mislocalisation. Furthermore, the c-terminal helices are less likely to 
participate in the core fold as it could be seen in the structures of the leucine transporter 
LeuT (Yamashita et al., 2005), benzyl-hydantoin transporter Mhp1 (Weyand et al., 2008) 
or the sodium/galactose symporter vSGLT (Faham et al., 2008), therefore mutations in this 
region might have a relatively limited effect on thermostability. Furthermore, it has been 
shown that thermostable mutations appeared frequently at the hinge regions, i.e. in the loop 
residues close to the membrane surface (Zhou et al., 2000; Bowie, 2001).  
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Figure 7. Targeted regions of YdgR.8 The fragments targeted in the random mutagenesis 
reactions are highlighted in purple.  
 
 
 
The mutagenic PCR reaction was performed in 50 µl of 1x Mutazyme reaction buffer 
containing 250 ng of the respective primer mixture (Tab. 3), 800 µM dNTPs, 2.5 U/µl 
Mutazyme II DNA polymerase and varying amount of template plasmid pET-YdgR-GFP. 
The reaction cycle is shown in Table 4. As already mentioned, the mutation frequencies 
greatly depend on the components in the PCR reaction and on the fragment length. 
Therefore, the concentration of template DNA was varied in order to achieve a sufficient 
mutation density. Before the elongation of the megaprimer, these frequencies were 
determined by blunting the amplified, mutated fragments and cloning them into the pJET 
vector using the GeneJET Cloning Kit (Fermentas). Ten different clones for each DNA 
template concentration were sequenced. In the second PCR reaction, the elongation of the 
plasmid was performed according to protocol with the reaction cycle shown in Table 4 
(with gel-purified fragments). 
 
 
 
 
 
 
                                                 
8 Figure generated with www.sacs.ucsf.edu/TOPO2-run/wtopo2.pl 
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Table 3. Primer pairs used in the first PCR reaction. 
Primer 
 
Sequence Used annealing 
temperature 
Loop1/4_Fw 5’ ATGGCTGTTTACCTGGTTAAAC 3’ 50 
Loop1/4_Rev 5’ CAGACGCGGGTCGTTTTTCTCATA 3’  
Loop6/7_Fw 5’ TGGAGTGTTGCGTTTGCGTTGAGC 3’ 53 
Loop6/7_Rev 5’ GCGATCAGTGCCACAACACCAATAA 3’  
Helix8_Fw  5’ TATCGCCACCTGGCTGCTG 3’ 50 
Helix8_Rev 5’ ATCATTTTACGACGCGCAGCACC 3’  
Helix 9/loop_Fw 5’ CTTCGCGATGAAAGGTGCTGC 3’ 50 
Helix 9/loop_Rev 5’ GACTACCGATGATGATCCAGAAC 3’  
Helix 11_Fw 5’ AAGATGGGCGATACCCTGCC 3’ 49 
Helix 11_Rev 5’ CAGCCAGCTTACAGACACGAT 3’  
 
 
Table 4. Mutagenic PCR reaction cycles 
 Fragment mutation (PCR 1)   Fragment elongation (PCR 2) 
Step  Temperature Time  Temperature Time 
Initial 
denaturation 
 95°C 2 minutes  95°C 1 minute 
Denaturation  95°C 30 seconds  95°C 50 seconds 
Annealing   30x 50-55°C 30 seconds     25x 60°C 50 seconds 
Extension  72°C 30 seconds  68°C 12.5 minutes 
Final extension  72°C 10 minutes  - - 
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The values for the mutation frequencies are not very accurate since only 10 clones were 
analyzed for each determination. However, they should ensure that there are not too many 
wildtype genes left in the screen. 
 
Library Loop 1/4 Although only 5 or 10 ng were used in the mutagenesis reaction, the 
libraries had mutation frequencies of 20 and 30 %, respectively. The 
mutagenesis has to be repeated with even lower concentrations 
 
Library Loop 6/7 Using 25 ng of pET-YdgR-GFP, 60% carried a single mutation, 30 % 
had two point mutations or insertions, respectively, and 10 % had four 
point mutations. 
 
Library Helix 8/9 Originally, the libraries for helix 8 and helix 9 should have been 
established separately. However, the achieved mutation frequencies 
for this part of the protein were always too low. Therefore, these two 
fragments were combined using Helix 8 forward and the Helix 9/loop 
reverse primers for the PCR. A template concentration of 10 ng 
yielded 43 % of the clones with one point mutation, 29 % with two, 14 
% with three and 14 % with no mutation. 
 
Library Helix 11 Two nanograms were used for the first PCR. They showed a mutation 
frequency of 100 % (1 point mutation) 
 
 
 
2.2.1.7. GFP fusion cloning 
A GFP-tag (green fluorescent protein) was added to the C-terminus of YdgR and the 
mutant Y156A in the pCS19 vector using two different approaches, namely cloning with 
restriction enzymes and In-Fusion Cloning (Clontech). The GFP gene was amplified from 
a pET-GFP vector using the primers given in Table 5. 
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Table 5. Primer pairs for cloning of a C-terminal GFP-tag. 
Primer name 
 
Function Sequence 
GFPtag_fw Standard cloning 5’GAAGATCTGAAAACCTGTACTTCC
AGGG 3’ 
GFPtag_rev  5’TCGGATCCTCAGTGGTGGTGGTGG
TG  3’ 
INF_GFPtag1_fw In-Fusion cloning 5’GCCGTAGCGAGATCTGAAAACCTG
TACTT CCAGGG 3’ 
INF_GFPtag2_fw In-Fusion, additional 
GGS linker 
5’AGCCGTAGCGAGATCTGGAGGTTC
CGAAAACCTGTACTTCCAGGG 3’ 
INF_GFPtag3_fw In-Fusion, control for 
GFP expression 
5’GGAGGATCCAGATCTATGGAAAAC
CTGTA CTTCCAGGG 3’ 
INF_GFPtag_rev Reverse primer for all 
three reactions 
5’TCAGCTAATTAAGCTACTAGTTCA
GTGGTG GTGGTGGTG 3’ 
 
 
The standard PCR reaction (Tab. 6) was performed in 50 µl 1x HF Buffer and 0.02 U/µl 
Phusion polymerase (Finnzymes) containing 800 µM dNTPs, 200 nM primers and 25 ng 
DNA template (pET-YdgR-GFP). The fragment was gel purified and cut with the 
restriction enzymes BglII and BamHI. The vector pCS19-YdgR was treated with BglII and 
alkaline phosphatase. Digested vector plus the fragment in a 5 x molar excess were ligated, 
transformed into DH5α and plated onto LB-ampicillin plates. Clones were checked for an 
insert via a restriction analysis and sequenced. The following mutant proteins were also 
cloned as a GFP construct in pCS19: M154K, L190V, A184T, N196K and F197I. The 
fragments were cut out of the pCS19 vector containing the respective mutant gene, gel 
purified, digested with EcoRI and BglII, and ligated into pCS19-GFP, from which the 
wildtype YdgR had been excised with the same restriction enzymes. 
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Table 6. Reaction cycle of GFP cloning. 
Step  Temperature Time 
Initial 
denaturation 
 98°C 30 seconds
Denaturation  98°C 15 seconds
Annealing   25x 63°C 30 seconds
Extension  72°C 30 seconds
Final extension  72°C 5 minutes 
 
 
Whereas standard cloning procedures require restriction sites, the In-Fusion cloning system 
gets by without. The primers are designed normally, but with a 15 base pair extension, 
which is homologous to the linearized vector ends. The amplified fragment anneals and 
recombines into the vector (Fig. 8). 
 
Figure 8. The In-Fusion cloning protocol. 9 A gene of interest is amplified using primers with a 
15 bp extension homologous to the linearized vector ends. The PCR product can then anneal and 
inert into the vector by homologous recombination. 
 
 
                                                 
9 Figure taken from Clontech http://www.clontech.com/products/detail.asp?product_id=206261&tabno=2 
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2.2.2. In vivo Assays 
 
2.2.2.1. Growth Assay 
A growth assay was established to distinguish between active and loss-of-function mutants 
of YdgR. The mutant libraries were transformed into E. coli BL21(DE3) and inoculated 
into 1 ml LB/carbenicillin overnight cultures. In the assay, 2 µl of these cells were grown 
in 96 well plates in 200 µl of LB medium containing the antibiotic carbenicillin. 
Additionally, the antibiotic alafosfalin, which inhibits cell wall synthesis and is specifically 
taken up by YdgR, was added to an end concentration of 200 µg/ml. Protein expression 
was induced with 0.01 mM IPTG at OD600 0.3 (determined by using Synergy™ HT Multi-
Mode Microplate Reader, Biotek; corresponds to an OD of 0.6 in a normal 
spectrophotometer, Ultrospec 6300 pro, Amersham). OD600 was measured after 
inoculation, before induction, one hour after induction, and seven hours after induction.  
 
2.2.2.2. Transport assay 
Comparing the uptake level of substrate by mutant proteins to wildtype also required an in 
vivo transport assay. Using this assay, it was possible to determine whether the cells 
expressing YdgR or its mutant forms could still transport the dipeptide alanyl-lysine 
labeled with the fluorescent dye AMCA (N-7-amino-4-methylcoumarin-3-acetic acid).  
For this purpose BL21(DE3) cells were transformed with the respective pCS19 constructs. 
Two milliliter overnight cultures with LB containing 2 % glucose and carbenicillin were 
set up. 250 µl were pelleted, resuspended in fresh LB/glucose/carbenicillin and transferred 
to 25 ml of fresh LB/glucose/carbenicillin in a 100 ml baffled flask. The cells were grown 
for approximately 2.5 hours until they reached an OD600 of 0.6, when they were induced 
with 0.1 mM IPTG. After one hour of induction, the cells were placed on ice and 3.25*109 
cells (as estimated from OD600) were resuspended in 1 ml modified Krebs-buffer. 40 µl of 
cells were incubated with 10 µl of 500 µM β-Ala-Lys-AMCA (diluted from stock in 
Krebs-buffer) and 50 µl of Krebs-buffer (negative control: 60 µl Krebs-buffer) for 15 
minutes in a MultiScreen filter plate (Millipore) at 37°C with shaking. A competitor was 
also tested (50 µl of 20 mM alanyl-alanine dissolved in Krebs-buffer instead of buffer 
only). The supernatant was filtered through the plates using a Millipore MultiscreenHTS 
vacuum manifold. The cells were then washed with three times 200 µl of Krebs-buffer. 
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Substrate fluorescence was measured with a Synergy plate reader (excitation wavelength: 
360 nm, emission: 460 nm, Tungsten lamp, sensitivity 50). Serial dilutions of the cells 
from each construct were plated to confirm the actual cell concentration. The protein levels 
were compared by Western blotting. 
 
2.2.2.3. GFP-fluorescence assay 
As for the growth assay, BL21(DE3) cells were transformed with YdgR-GFP or the 
respective mutants. Colonies were inoculated into 1 ml overnight cultures. Cells grown in 
96 well plates for 2.5 hours were induced with 0.01 mM IPTG and YdgR-GFP 
fluorescence was determined after another 4 hours. Absorbance at 600 nm was also 
measured to confirm similar cell density of the samples. 
 
 
2.2.3. Protein expression 
 
2.2.3.1. Small-scale high-throughput purification (HTP) 
 
2.2.3.2.1. Expression 
The mutant libraries and the respective controls (wildtype, Y156A mutant, empty pCS19 
vector) were transformed into BL21(DE3) (see growth assay). 30 µl of pre-culture were 
inoculated into 2 ml LB/carbenicillin in 24 well plates, and grown to OD 0.6 (37°C, 200 
rpm). After induction with 0.1 mM IPTG, the temperature was reduced to 18°C and the 
cell were incubated with shaking overnight. The bacteria were harvested directly in the 
plates (4000 g, 10 minutes) and frozen at -20°C (also when processed the same day 
because freezing enhanced the lysis).  
 
2.2.3.2.2. Purification 
The cells were thawed, resuspended in 350 µl lysis buffer (20 mM Tris, pH 8, 150 mM 
NaCl, 10 % glycerol, 15 mM imidazole, 1 % DDM, 5 mM Ala-Ala, Complete protease 
inhibitors (Roche), 1 mg/ml lysozyme, 10 U/µl Benzonase (Sigma) and 2 mM MgCl2), and 
incubated on a shaker at 4°C for two hours. 40 µl of the same buffer with a higher salt 
concentration was added to increase the end concentration to 300 mM salt (Ni-NTA 
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binding optimum). Unlysed cells and cell debris were pelleted for 10 minutes at 4000 g. In 
the meantime, 96 well Ni-NTA plates with 50 µl beads (His Multitrap HP, GE Healthcare) 
were equilibrated with wash buffer (20 mM Tris, pH 8, 300 mM NaCl, 30 mM imidazole, 
10 % glycerol, 0.04 % DDM and 5 mM Ala-Ala. The supernatant was added to the beads, 
and the plates were incubated with shaking overnight at 4°C. The samples were then 
filtered through the plates using the Millipore vacuum manifold and washed with 1 ml 
wash buffer. The protein was eluted in 50 µl elution buffer (20 mM Tris, pH 8, 300 mM 
NaCl, 10 % glycerol, 150 mM imidazole, 0.02 % DDM and 5 mM Ala-Ala) and 
centrifuged at 500 g for 2 minutes (to avoid bubble formation in the solution during 
vacuum suction). 
 
 
2.2.3.2. Large-scale purification 
 
2.2.3.2.1. Expression 
YdgR was recombinantly expressed in C43(DE3) cells. This E. coli strain carries a 
mutation that leads to a larger membrane surface area and thus to an increase in protein 
yield (Walker et al., 1996). Therefore, the respective constructs were freshly transformed 
into this strain. 30 ml LB/glucose/carbenicillin medium in a 100 ml baffled flask was 
inoculated with one colony and grown overnight at 30 °C (200 rpm). These overnight 
cultures were pelleted and resuspended in 10 ml fresh medium. 3 ml of this cell suspension 
was transferred to 2 L LB/glucose/carbenicillin medium in 5 L baffled flasks (pre-rinsed 
with sterile dH2O). The cells were grown at 37°C at 190 rpm until they reached an OD600 
of 0.6. After induction with 0.1 mM IPTG (final concentration), the temperature was 
shifted to 18°C and the cells were grown overnight at 130 rpm to reduce the foaming. Cells 
were harvested by centrifugation at 15 000 g for 15 minutes, resuspended in 50 ml 
resuspension buffer per liter cell culture (50 mM Tris pH 8, 300 mM NaCl, 10% glycerol 
and 2 mM EDTA) and frozen at -80°C. 
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2.2.3.2.2. Membrane preparation 
A very important step towards the purification of membrane proteins is the isolation of 
membranes. First, it already serves as a purification step since cytosolic proteins are 
removed, and second, the starting material for the actual purification is more concentrated. 
The thawed cells were filtered through a 47 mm disc filter (Millipore) to remove lumps. 
After addition of Complete protease inhibitors (Roche), the cells were lysed using a French 
press (1.7 kbar). The lysate was centrifuged at 26 940 g for 45 minutes to remove the 
unlysed cells and cell debris. The supernatant was ultracentrifuged at 100 000 g for one 
hour. The pelleted membranes were homogenized using a glass homogenizer in 
homogenizer buffer (10 mM Tris pH 8, 20 mM NaCl, 20% glycerol). The protein 
concentration was determined by the Lowry method, and the membranes were diluted to 6 
mg/ml and frozen in liquid nitrogen and stored at -80°C. 
 
 
2.2.3.2.3. Purification 
 
YdgR was purified using a two-step protocol, consisting of metal affinity chromatography 
and size-exclusion chromatography. The gene is expressed with a 6x-His tag on the C-
Terminus, and can therefore bind to nickel ions (Ni2+) immobilized onto a stationary phase 
such as agarose or sepharose. Before the chromatography steps can be performed, 
however, the YdgR protein has to be solubilized from the membrane. 
 
2.2.3.2.3.1. Solubilization 
First, the membranes are thawed and diluted 1:1 with a dilution buffer resulting in an end-
concentration of 20 mM Tris, pH 8, 300 mM salt, 10 % glycerol, 1 % DDM and 5 mM of 
Ala-Ala (and also 0.5 mM DTT if the protein was not used for assays where DTT would 
disturb the reaction). After an hour of rotating at 4°C, the samples are centrifuged at 100 
000 g to spin down the non-solubilized membranes.  
 
2.2.3.2.3.2. Immobilized metal affinity chromatography (IMAC) 
The supernatant from ultracentrifugation was diluted 1:1 with a buffer containing 30 mM 
imidazole (end-concentrations: 15 mM imidazole, 0.5 % DDM). One milliliter of Ni-beads 
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(Qiagen, equilibrated in 20 mM Tris, pH 8, 300 mM NaCl, 10 % glycerol, 5 mM of Ala-
Ala and 0.04 % DDM) per 10 ml of 6 mg/ml membranes was added and the samples were 
incubated with rotating overnight at 4°C. The beads were poured into a Biorad polyprep 
chromatography column and washed with ten times the column volume of washing buffer 
(20 mM Tris, pH 8, 300 mM NaCl, 10 % glycerol, 30 mM imidazole, 0.04 % DDM and 5 
mM of Ala-Ala). The proteins were eluted in the same buffer containing 150 mM 
imidazole and 0.02 % DDM in five times two ml fractions (ten times the column volume 
with 10 minutes incubation time between the first and the second fraction to maximize 
protein yield). The fractions were analyzed on a Coomassie stained SDS-gel (Fig. 9).The 
YdgR protein band runs at approximately 39 kDa. YdgR has an expected molecular weight 
of 54 kDa assessed from its length (500 amino acids) However, it runs lower due to the 
abnormal migration behavior sometimes observed with membrane proteins (Weitz et al., 
2007). There was very little protein in the wash steps.  The majority of protein eluted in the 
first two elution fractions, which were pooled and concentrated in a Vivaspin 6 (Sartorius) 
with a 50 kDa molecular weight cut-off (MWCO) to 500 µl. The micelle including the 
protein should have a molecular mass of approximately 150 kDa, therefore, a MWCO of 
50 kDa should allow for concentration of the protein. 
 
Figure 9. Coomassie stained SDS-gel of immobilized metal affinity chromatography (IMAC). 
YdgR containing a C-terminal His-tag was purified over a nickel-agarose column. The fractions 
were analyzed on a Coomassie stained SDS-PAGE. The protein runs at approximately 39 kDa, and 
eluted in the first four milliliters of the elution fractions. 
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2.2.3.2.3.2. Size exclusion chromatography  
Size exclusion chromatography or gel filtration is a chromatographic method that separates 
compounds according to their size (the so-called hydrodynamic volume, which not only 
includes the molecular weight, but also the shape of the molecule). The column is 
composed of a highly porous polymer material of a certain diameter. Smaller molecules 
are retained in these pores whereas larger particles can diffuse through much faster, and are 
therefore eluted first. This principle can not only be exploited to separate differently sized 
proteins, but also to exchange or remove buffer components. 
Pooled and concentrated fractions from the Ni-NTA eluate were loaded onto a Sephadex 
200 column (GE Healthcare), equilibrated in 20 mM Tris, 150 mM NaCl, 10 % glycerol 
and 0.04 % DDM and chromatographed with a flow of 0.5 ml/minute. YdgR eluted at a 
column volume of approximately 13 ml (peak maximum), which corresponds to 150 kDa 
(data Peggy Stolt-Bergner). Fractions were analyzed on a SDS-gel, pooled and 
concentrated if necessary. One example of a YdgR gel filtration chromatogram is given in 
Figure 10A . Fractions C1 to C13 can be seen in lane 4 to 15 on the Coomassie stained gel 
(Fig. 10B). Compared to the pool after the Ni-IMAC (lane 2), the protein is relatively pure. 
The Vivaspin flowthrough sample did not contain any protein, which means that the 
MWCO of the concentration column is small enough to retain the protein.  Fractions C8 to 
C13 were pooled and frozen. 
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A 
 
 
B 
Figure 10. Gel filtration of IMAC purified YdgR. (A) Gel filtration chromatogram and (B) 
Coomassie stained SDS-PAGE of the eluate. YdgR eluted at approximately 13 ml, which 
corresponds to its molecular weight plus micelle (150 kDa). 
 
 
 
2.2.4. Protein Analysis  
 
2.2.4.1. SDS-polyacrylamid gel electrophoresis (SDS-PAGE) 
SDS-polyacrylamide gel electrophoresis is a widely used technique to separate proteins 
according to their molecular weight. The proteins are denatured in a buffer containing 
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SDS, which renders the protein negatively charged. As already mentioned, SDS (Fig 4A) 
is a detergent, an amphiphilic molecule with a negatively charged polar head (sulfate 
group) and a hydrophobic tail that adsorbs to the protein. 
5x SDS loading buffer was added the protein samples, which were then loaded onto a 12 % 
SDS polyacrylamide gel. The gel is divided into a separating gel (lower part, 12 % 
bis/acrylamide, 375 mM Tris pH 8.8, 0.1 % SDS, 0.1 % ammonium persulfate (APS), 0.04 
% N,N,N′,N′-Tetramethylethylenediamine (TEMED)) and a stacking gel (upper part, 
loading pockets, 5 % bis/acrylamide, 125 mM Tris pH 6.8, 0.1 % SDS, 0.1 % APS, 0.1 % 
TEMED). The proteins were electrophoresed for one hour at 160 Volts.  
 
2.2.4.2. Coomassie Staining 
Coomassie dyes are commonly used to stain polyacrylamide gels by adsorption to certain 
amino acids in a protein. Here, a PageBlue protein staining solution from Fermentas was 
used, and gels were stained according to the provided fast protocol. 
 
2.2.4.3. Silver staining 
The advantage of silver over Coomassie staining is that its detection limit is about 100 
times lower. In principle, silver ions bind to the protein, where they are reduced to metallic 
silver, and thus produce a band on the gel. 
The PAA gel was fixed in 60 ml 50 % (v/v) acetone, 1.25 % (w/v) trichloroacetic acid 
(TCA) and 0.015 % (w/w) formaldehyde. After washing with dH2O for 3x 5 seconds, 5 
minutes and another 3x 5 seconds, the gel was incubated another 5 minutes with 60 ml 50 
% (v/v) acetone. It was soaked in 60 ml 0.017 % (w/v) sodium thiosulfate (Na2O3S2 in 
dH2O), washed with water (3x 5 seconds) followed by an eight minute incubation in a 
solution of 0.27 % (w/v) silver nitrate (AgNO3), 0.37 % (w/w) formaldehyde. After an 
additional wash step (dH20, 5x 5 seconds), the stain was developed in 60 ml 195 mM 
sodium carbonate, 0.015 % (w/w) formaldehyde and 0.004 % (w/v) Na2O3S2 in dH2O. The 
reaction was stopped in 1 % (v/v) glacial acetic acid. 
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2.2.4.4. Western blotting 
A SDS-PAGE was run with a pre-stained protein ladder and transferred to a PVDF 
membrane (Millipore Immobilon-P PVDF, 0.45 µm). The membrane was first activated 
with methanol (5 minutes), washed in dH2O (1 minute) and transfer buffer (5 minutes). 
The assembled gel sandwich was run in 1x transfer buffer at 400 milliampere (mA) for 1.5 
hours at 4°C (Hoefer TE 22 Mighty Small Transphor Electrophoresis unit, GE Healthcare). 
The membrane was blocked in 5 % milk in TBS-T, incubated on a shaker with a Qiagen 
penta-His antibody (diluted in 5 % milk/TBS-T) at 4°C overnight. The blot was rinsed 3 
times, washed 5x 7 minutes with TBS-T and incubated with a 1:20 diluted solution of the 
ECL Western blot detection kit (GE Healthcare). 
 
 
2.2.4.5. Determination of protein concentration 
There are several methods to determine protein concentration in solution. The following 
protein assays were used to quantitate proteins. 
 
2.2.4.5.1. Absorbance 260/280 nm 
Measuring absorbance at 260/280 nm, and calculating the concentration is quite simple, 
but not very sensitive (depending primarily on the absorbance of the amino acids 
tryptophan and tyrosine). 260/280 nm measurements were always performed using a 
Nanodrop spectrophotometer (Thermo Scientific) unless stated differently.  
 
2.2.4.5.2. Lowry 
In this colorimetric assay, a complex between the peptide bonds and divalent copper ions 
(Cu2+) is formed in an alkaline solution (Biuret-reaction). Then, Cu2+ is reduced to 
monovalent copper (Cu+), which in turn reduces the yellow Folin-reagent. The solution 
turns blue, and absorption can be measured at 750 nm. Here, the Lowry assay was 
performed using a BioRad Dc protein assay kit and a BSA standard curve.  
 
2.2.4.5.3. Fluoraldehyde assay (Pierce) 
The reagent o-phthalaldehyde (OPA) reacts with the amino terminus of peptide chains to 
form a compound that is excited at 330-390 nm and emits light at 436 - 475 nm and can 
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therefore be used to determine protein concentrations. However, it also reacts with amino 
acids containing a primary amino group or Tris, so the buffer conditions have to be chosen 
carefully, and a standard curve should be preferentially done with the same 
peptide/protein. The assay has a quite low detection limit and is compatible with detergent 
and imidazole, two prerequisites for measuring concentrations of the high throughput 
purified protein used in these experiments. Protein concentrations from 0.05 mg/ml to 0.3 
mg/ml yielded a linear curve, and were therefore used to generate a standard curve. The 
samples from the HTP purification were measured undiluted (excitation: 360 nm, 
emission: 460 nm). 
 
2.2.4.5.4. 660 nm assay (Pierce) 
The reagent contains a complex that interacts with basic amino acids such as arginine, 
lysine and histidine, but also with phenylalanine, tyrosine and tryptophan, and absorbs at a 
wavelength of 660 nm. The assay was used in a microplate format according to the 
provided protocol. 
 
 
2.2.4.6. Stargazer Screen (Harbinger biotech) 
The stability of a protein can be measured by its melting temperature Tm, i.e. the 
temperature at which the protein unfolds or denatures. The Tm of a protein can be 
determined by several methods, for example differential scanning calorimetry (DSC). 
However, a major drawback of these methods is that only one sample can be measured at a 
time. As the protein unfolds, it forms particles of increasing size in solution, which can be 
measured by static light scattering. Exactly this principle is adopted by the Stargazer assay. 
The machine itself consists of a heating block with an underlying light source (LEDs) and 
an overhead camera (Fig. 11A). The samples are measured in 384 well plates, which 
allows one to assay many different conditions, for example buffers, ligands or mutant 
proteins, at the same time. The heating block heats the sample, and an image (Fig. 11B) is 
captured every 0.5 °C. The increase in static light (see circle, Fig. 11C) scattering is 
determined via a provided program (Harbinger Biotech, Intensities). The increase in light 
intensity is integrated into a melting curve (Bioactive program), from which the 
aggregation temperature (Tagg) can be calculated. The Tagg is not the same as the Tm, but 
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both values should lie in a very similar range. The Stargazer cannot be used to determine 
exact melting temperatures, but to compare aggregation temperatures in different 
conditions to each other. 
Protein samples for Stargazer assays were pipetted into Nunc 384 well optical bottom 
black plates in 50 µl aliquots, to a final concentration of 0.1 to 0.2 mg/ml (duplicates). 50 
µl of mineral oil were overlayed, and the plates were centrifuged at 3000 g for 5 minutes. 
Well A24 always contained only buffer and oil (temperature measure well). 
 
 
A 
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B 
 
 
C C 
Figure 11. The Stargazer. (A) 10 Schematic representation of the Stargazer setup. A heat block 
with an underlying LED source heats up to protein samples, while an overhead camera takes a 
picture every 0.5 °C. (B) Picture of a 384 well plate taken by the camera. (C) 11 Enlarged image of 
one well at two different temperatures. The scattered light lies between the reflected and the 
incident light. The increase in scattered light can easily be seen in the left panel (see circle) 
                                                 
10 Figure taken from Senisterra et al., 2006 
11 From StargazerTM-384, High through-put protein stability analyzer product brief, Harbinger Biotech 
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3. Results 
 
 
 
 
 
 
 
The important thing in science is not so much to obtain new facts  
as to discover new ways of thinking about them. 
 
Sir William Bragg (1890-1971) 
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3.1. Optimization of the assays 
 
3.1.1. Optimization of the growth assay 
 
This simple and fast growth assay relies on the ability of YdgR to take up various 
substrates, including an antibiotic called alafosfalin (Hahn, 1981). This toxin is a 
phosphonopeptide (Fig. 12) and inhibits cell wall synthesis, and is a specific substrate for 
YdgR. YhiP, one of the family members, also transports alafosfalin, but to a lower extend 
than YdgR (Harder et al., 2008). Therefore, cells can only survive in the presence of this 
antibiotic when they express a loss-of-function YdgR mutant, but not when expressing 
wildtype protein (or a functional mutant). 
 
 
Figure 12. The phosphonopeptide alafosfalin.12 YdgR takes up the peptidomimetic antibiotic 
alafosfalin, which inhibits cell wall synthesis. 
 
 
 
First, the growth assay had to be optimised. Cells expressing the mutant proteins were 
grown in a 96 well plate format in the presence of alafosfalin, and their OD600 was 
measured at different time points. Several different conditions for the assay were 
investigated. First, three different cell types were chosen, namely BL21(DE3), which is 
generally a good strain for expressing high levels of proteins, C43(DE3), a strain that 
carries an unknown mutation making it more suitable for membrane protein expression, 
and the YdgR knock out strain JW1626, which has the advantage of expressing 
recombinant YdgR-His without any native background. Furthermore, the cells were 
induced with either 0.01 or 0.1 mM IPTG, and were grown with either 200 or 500 µg/ml 
alafosfalin. Induction with higher concentrations of IPTG seemed to decrease cell growth, 
most probably because elevated levels of expressed YdgR were toxic for the cells. Also, a 
                                                 
12 Figure taken from Hahn, 1981 
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high concentration of alafosfalin was detrimental to cell growth, even when recombinant 
YdgR was not expressed. Probably natively expressed YdgR, or its family members in the 
case of the delta strain, was enough to take up the noxious compound. After several 
experiments, it was clear that the BL21(DE3) cells grown in 200 µg/ml antibiotic and 
induced with 0.01 mM IPTG yielded the most reproducible and reliable results. In Figure 
13B, several wildtype and mutant cultures are shown. The wildtype cells started to die one 
hour after induction, whereas the L-O-F mutant, a Y156A mutation in the FYING-PTR 
motif, expressing cells continue to grow. The uninduced cells treated with alafosfalin grew 
much slower than the control cells without the toxin (Figure 13A).  
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Figure 13. Growth assay with alafosfalin. (A) Only loss-of-function mutants can survive in the 
presence of the antibiotic alafosfalin (yellow) since they do not take up the toxin. Cells expressing 
wildtype protein (black) start to die approximately one hour after induction. Control cells without 
alafosfalin grow much better (wildtype: pink, L-O-F mutant: turquoise) than the uninduced control 
with the antibiotic (wildtype: purple, L-O-F- mutant: brown). (B) Control experiment with several 
wildtype (bright colors) and the loss-of-function mutant Y156A (pastel-colored) cultures. 
BL21(DE3) cells induced with 0.01 mM IPTG and grown in the presence of 200 µg/ml alafosfalin 
yielded the most reliable results. 
 
 
 
 
 
Results  43 
3.1.2. Optimization of the purification 
 
3.2.1.1. Growth and expression 
Concomitantly with the growth assay in the screen, the same mutant proteins should be 
expressed in small cultures for the high-throughput purification. Therefore, growth and 
protein production had to be optimised.  
The pre-cultures already used in the growth assay were inoculated in 1 ml LB/carbenicillin 
in 96 well plates. After several trial purifications, it was decided that these cultures simply 
yielded too little protein. Therefore, the volume was increased to 2 ml, and the cells were 
grown in 4x 24 well plates instead where better aeration and therefore better cell growth 
and expression resulted than in the smaller wells. It was also tested, which of the three cell 
types, BL21(DE3), C43(DE3) and JW1626, expressed the most protein. YdgR containing a 
c-terminal GFP-tag and the Y156A mutant were expressed in these cell lines and analysed 
on a Western Blot (Fig. 14). BL21(DE3) exhibited the highest protein levels compared to 
the other two (see arrow).  
 
Figure 14. Expression of YdgR-GFP in different cell lines. Western blot of BL21(DE3), 
C43(DE3) and JW1626 expressing a YdgR-GFP construct. The Escherichia coli BL21(DE3) strain 
was found to express the highest levels of YdgR-GFP (arrow) when compared to C43(DE3) and 
knock-out strain JW1626. As a positive control, purified YdgR (without GFP-tag) was added. The 
empty vector expressed only GFP (band at 26 kDa). 
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3.2.1.2. Lysis 
Initially, the lysis buffer contained 20 mM Tris, 300 mM salt, 15 mM imidazole. 
Furthermore, 1 % DDM (Fig. 15A) to solubilize the membrane, 5 mM substrate (A-A) to 
stabilize the YdgR transporter, 1 mg/ml lysozyme to enhance bacterial lysis, 10 U/ml 
Benzonase to digest nucleic acids, Complete protease inhibitor to protect YdgR from 
degradation and the reductive agent DTT were added. The buffer was added to the bacteria 
pellet, and lysis was carried out with shaking at 4°C for one hour. Since the lysis was not 
very efficient, I tried to optimise it by changing the lysis method. The original approach 
was compared to sonication, lysis with a different detergent (foscholine-12, FOS-12, 
Figure 15B) and the commercially available lysis buffer BugBuster (Novagen). A silver 
stained SDS-Page of the high throughput purified proteins is shown in Figure 15C. The 
membranes solubilized with the detergent FOS-12 yielded the highest level of protein, 
whereas DDM and sonication displayed fairly equal but lower concentrations. BugBuster, 
however, seemed to be the least suitable method since there are no protein bands visible on 
the silver stain. 
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A 
 
B 
 
C 
Figure 15. Optimization of lysis. Structure representation of the detergents (A) 13 
dodecylmaltoside and (B) 14 foscholin-12. (C) Solubilization of YdgR from BL21 (DE3) by 4 
different methods: The detergent foscholin-12 yielded the highest protein levels, whereas 
solubilization with DDM and sonication gave remarkably lower protein levels. Using the 
commercially available BugBuster (Novagen) did not work for YdgR solubilization. 
 
 
 
FOS-12 is a fairly aggressive detergent, effective at solubilization, but often also 
detrimental for protein stability. Therefore, a purification of YdgR and a subsequent 
analysis on an analytical gel filtration column should allow for determination of the protein 
quality when solubilized with different detergents. The protein was solubilized out of 
prepared membranes with DDM or FOS-12 or a mixture of both. It was then purified over 
a Ni-NTA column and run on a gel filtration column (Superdex 200 PC 3.2/30, 
Äktaexplorer Ettan, GE Healthcare). The detergent concentrations for lysis, wash and 
elution buffers and their respective ratios are given in Table 7.  
                                                 
13 Figure taken from http://www.chemblink.com/products/69227-93-6.htm 
14 Figure taken  from http://pubchem.ncbi.nlm.nih.gov/ 
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Table 7. FOS-12/DDM detergent ratios and concentrations. 
 Lysis Buffer 
FOS-12/DDM 
Washing Buffer 
FOS-12/DDM 
Elution Buffer 
FOS-12/DDM 
FOS:DDM 
ratio 
1 1  % FOS-12 0.2  % FOS-12 0.1 % FOS-12  
2 1  % FOS-12 
 
0.2 % FOS-12, detergent 
exchange to 0.04 % DDM 
0.02 % DDM  
3 1 % DDM 0.04 % DDM 0.02 % DDM  
4 1 % /0.04 %  0.2 % / 0.01 % 0.2 % / 0.01 %  4:1 
5 0.8 % /0.7 % 0.2 % / 0.02 %  0.1 % / 0.01 % 2:1 
6 0.5 % / 0.1 %  0.2 % / 0.04 %  0.1 % / 0.02 %  1:1 
7 0.5 % / 0.2 %  0.2 % / 0.1 % 0.1 % / 0.04 % 1:2 
 
 
Instead of a single peak, which is present in DDM purified protein, FOS-12 detergent 
indeed had a negative effect on protein stability. Before the peak corresponding to 
monomeric protein, there was a second peak, which most probably represents aggregated 
protein (Fig. 16). This peak could be diminished when FOS-12 was gradually decreased 
and DDM was increased. When the FOS-12 was replaced with DDM in a detergent 
exchange step during washing, the second peak disappeared, but the size still corresponds 
to aggregated protein. The conjecture that FOS-12 destabilized the protein is further 
enhanced by the fact that protein purified in FOS-12 or protein samples where FOS-12 has 
been added after purification, showed no melting curves in Stargazer assays, but rather 
behaved like aggregated protein. FOS-12 is therefore not suitable for high-throughput 
purification. The detergent exchange during purification is not an alternative either because 
the protein yield was much too low. 
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A C 
B D 
Figure 16. Gel filtration chromatograms of YdgR purified in FOS-12/DDM. (A) Protein 
purified in only DDM does not show any aggregates, only one peak corresponding to monomeric 
protein. (B) YdgR purified in FOS-12 gave two peaks, the first of which probably corresponds to 
aggregated protein. (C) The higher the DDM concentration, the lower this aggregate peak becomes. 
(D) A detergent exchange gives only an aggregate peak, and greatly decreases protein 
concentration (upper peak in panel D 10 times enlarged). 
 
 
 
Since none of the tested lysis methods worked, and DDM seemed to be an excellent 
detergent for the purification of YdgR, I tried to enhance lysis in DDM containing buffer 
instead. It was observed that the lysed samples were very viscous, which might be 
detrimental for binding to the nickel-beads. Increasing the volume of the lysis buffer did 
not enhance the concentration of purified protein. By decreasing the salt concentration to 
150 mM and adding 2 mM magnesium chloride to the buffer to improve Benzonase 
function, viscosity decreased considerably. Furthermore, the lysis time was expanded to 
two hours, and a freeze-thawing cycle (-20°C → room temperature) was added to improve 
lysis. 
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3.2.1.3. Purification 
Initially, HTP purification trials were performed with Qiagen Ni-beads with a washing 
buffer volume of 500 µl. This yielded a considerably pure protein, so about 500 mutants 
were screened in these conditions. However, it was not considered that switching from 
initial trials to the high throughput screen i.e. from 1 ml to 2 ml cultures and from Qiagen 
Ni-NTA in BioRad columns to GE Healthcare pre-pipetted Ni-plates, would lead to much 
less pure protein purifications (Fig. 17A). Increasing the washing buffer helped greatly 
(Fig. 17B), but it also reduced YdgR concentration, so the Stargazer assay could not be run 
in duplicates anymore. So far, the lysate had been incubated with the Ni-beads overnight to 
increase the protein yield. However, determination of protein concentration from samples 
incubated overnight or for ten minutes showed that actually a shorter incubation led to 
higher protein levels. A summary of the optimized purification protocol is given in Table 
8. 
 
            
A B 
Figure 17. High-throughput purification of YdgR. The protein levels of HTP purified protein 
from (A) Qiagen Ni-NTA and (B) GE-Healthcare pre-pipetted plates were compared in a silver 
staining of a SDS-PAGE.  
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Table 8. Optimization of the HTP expression and purification. 
 Initial protocol Optimised protocol 
Expression 1 ml culture 2 ml culture 
 96 well plate 4x 24 well plates 
HTP purification 100 µl lysis buffer 350 µl lysis buffer 
 1 hour lysis 2 hours lysis 
 Detergent: DDM DDM 
 300 mM NaCl in lysis buffer 150 mM NaCl 
 No MgCl2 2 mM MgCl2
  Freeze-thaw cycle 
 500 µl wash buffer 1 ml wash buffer 
 Overnight binding to Ni-NTA 10 minutes binding 
 
 
3.1.3. Establishment and optimization of the Stargazer thermostability assay 
 
The Stargazer assay was a new methodology established in this laboratory. First, purified 
YdgR was assayed for its thermostability in different buffers in different concentrations. 
These experiments were all performed in small, black 384 well optical bottom plates, each 
well accommodating only 10 µl of protein sample (0.1 – 0.2 mg/ml). The advantage of the 
smaller plates compared to the bigger ones, which need 50 µl of protein solution, is 
obviously that much less sample protein is needed. However, during the initial experiments 
it turned out that the error in the smaller plates was much higher than in the larger volume 
plates.  
YdgR had different stabilities in different buffer conditions. Furthermore, some buffers 
seemed to completely denature the protein, because no interpretable aggregation curve 
could be obtained. An example for three different buffers is shown in Figure 18. 50 mM 
MES with 150 mM NaCl, pH 6 gave a reasonable aggregation curve and an aggregation 
temperature of 61.2 °C (dark blue). The stability could be further increased by 4 °C in a 50 
mM pyridine buffer with 150 mM NaCl, pH 5.5 (green). However, in 50 mM PIPES with 
500 mM KAc, pH 7 (light blue) the curve is not sigmoidal and therefore could not be 
interpreted. Linear regression gave a thermal stability of 140°C, which is of course 
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relatively unlikely. Also, the concentration dependence of the assay was tested. In the 
small 10 µl plates, the average aggregation temperature for both 0.1 and 0.2 mg/ml 
samples was about 64°C. Switching from the 10 µl to the 50 µl plates rendered the assay 
much more reproducible, and it was observed that there actually was a concentration 
dependency. 
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Figure 18. Aggregation temperature curves from a Stargazer experiment. Three different 
buffers are compared. When switching from 50 mM MES and 150 mM NaCl, pH 6 (dark blue) to 
50 mM pyridine and 150 mM NaCl, pH 5.5 (green), the thermal stability is increased by 4°C. 
However, certain buffers such as 50 mM PIPES with 500 mM KAc, pH 7 (light blue) resulted in 
non-interpretable data. 
 
 
 
3.2. Result of the screen 
 
Summarizing the screen, the mutant library and wildtype, empty vector and the Y156A 
loss-of-function mutant as controls were transformed into BL21(DE3), a growth assay 
distinguished between functional and loss-of function mutants, the same mutant clones 
were grown as 2 ml cultures, from which the protein was high-throughput purified in Tris 
buffer and DDM, and the thermostability was determined in a Stargazer thermostability 
assay (Fig. 19).  
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Figure 19. Scheme of the complete thermostability screening protocol. The mutant library is 
transformed into E. coli BL21(DE3), 1 ml overnight pre-cultures are used for both the growth assay 
(left) and the expression of the mutant clones in 2 ml cultures. The YdgR mutant proteins are high-
throughput purified and analysed in a Stargazer thermostability assay. 
 
 
 
I screened 720 mutants from the loop 6/7 library targeting transmembrane domains 6 and 7 
and the interjacent loop domain. 630 of those mutants also underwent the Stargazer 
thermostability assay. Furthermore, 350 mutant clones in transmembrane helices 8 and 9 
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plus their intermediary loops were tested, 260 of which were assayed for their 
thermostability. The screen was performed in the above mentioned conditions (see Results 
3.1.). The mutants from library loop 6/7 were purified with 500 µl wash buffer and hence 
were much dirtier than the protein purified later on.  
 
 
3.2.1. Mutation frequencies 
 
3.2.1.1. Library loop 6/7 
The 720 mutants from this library resulted in 13 % loss-of-function mutants. Many of these 
were due to insertions or deletions usually resulting in a frame shift, and hence in a 
truncated version of the protein. The Stratagene mutagenesis kit promised an insertion 
frequency of 0.7 % and a deletion frequency of 4.8 %. The actual frequencies found were 
approximately 2 % single base insertions and 0.97 % single base deletions. However, many 
insertions were simply a duplication of parts of the mutated fragment indicating that the 
second PCR, in which the whole vector was amplified using the mutagenized fragment as a 
primer, did not work properly, possibly due to secondary structures in the fragment or base 
pairing of two fragments.  
 
3.2.1.2. Library helix 8/9 
Of the 350 mutant clones tested from this library, about 22 % were loss-of-function 
mutants. Sequencing analysis revealed that the second PCR step completing the plasmid 
worked much better for this library. Only two out of 76 loss-of-function mutants had a 
longer fragment inserted (i.e. 2.6 % of the L-O-F mutants, 0.6 % of the total library). The 
single base insertion and deletion frequencies amounted to 1.3 % and 15.8 %, respectively 
(corresponding to 0.3 % and 3.4 % of the total library). Generally, the quality of this 
library was better since also the mutation frequencies were relatively high: 26.3 % of the 
L-O-F mutants carried a single point mutation, 22.4 % had two and 3.9 % three point 
mutations (insertion and deletion clones as well as plasmids without interpretable 
sequencing data cover the remaining percent). The overall mutation frequency is not 
known since none of the functional mutants were sequenced. 
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3.2.2. Growth assay 
In the first 180 clones screened of library loop 6/7, about 12 % were loss-of-function 
mutants. Only 18 % had point mutations, whereas over 59 % contained a long insert. In 
order to reduce DNA preparation and sequencing efforts, I established a colony PCR 
protocol to determine the length of the mutated fragment to exclude mutants with a long 
insertion. Taking together the results from all 720 mutants screened for transmembrane 
helix 6 and 7, 13 % of those were loss-function mutants, approximately half of which (53.2 
%) had a long insertion (7 % of the total clones screened). Although the overall mutation 
frequency had been determined beforehand by sequencing 10 clones (6: single point 
mutation, 3: two point mutations or insertions, 1: four point mutations) in order to 
guarantee a reasonably high frequency, it turned out that the actual mutation frequencies 
were much lower, meaning that there were still many wildtype clones left in the screen.  
Sequencing of the loss-of-function mutants yielded only 8 single point mutations: M154K, 
A184T, L190V, N196K and F197I. The L190V mutant was found 3 times and the F197I 
two times. The remaining sequenced clones either had single base deletions or insertions, 
which led to a frameshift, or codons that were transformed into stop codons.  
The following loss-of-function mutations were found in the growth assay of the screen of 
library helix 8/9: L249R, V252E, A264P, K274I, A285V, F289L, F289S, M295K (2 
times), T297A, N300D, N300Y, F301I, A303G, R305C, N306I, Q320L, L324V (2 times) 
and P326Q. They are shown together with the loss-of-function mutations from library loop 
6/7 in Figure 20 (purple, targeted regions: squares).  Furthermore, four truncated versions 
of the protein resulted in a total loss-of-function: E263stop, K268stop, Q320stop and 
P326stop. 
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Figure 20. Topological representation of YdgR from Helix 5 to Helix 10 with loss-of-function 
mutations.15 Loss-of-function mutations found in the growth assays of libraries loop 6/7 and helix 
8/9 (regions indicated as squares) are highlighted in purple. 
 
 
 
3.2.3. Thermostable mutant candidates  
 
The determination of thermostability from library helix 6/7 yielded 45 candidates that had 
a higher aggregation temperature than the wildtype. Since the wildtype protein gave 
different temperatures from run to run, it was always high-throughput purified as an 
internal control, as well as the Y156A mutant, which was usually 2 to 3 °C lower than the 
wildtype. Also, the empty vector was expressed as a negative control, and never yielded 
any melting curves. Only 9 of these 45 sequenced thermostable mutants carried a mutation 
indicating that the screen detected a high number of false positives (see below). Table 9 
lists the mutations that were found and their increase in aggregation temperature compared 
to the wildtype.  
A leucine 190 to valine mutation, which was already found three times in the loss-of-
function screen, was found twice in the thermostability assay. Also, a threonine mutation at 
position 193 appeared twice (T193 to alanine, T193 to isoleucine), and the adjacent 
isoleucine 194 was also found to be more thermostable. Asparagine 217 also was detected 
two times, one mutation to lysine and one to serine. A lysine at position 210 mutated to 
                                                 
15 Figure generated with www.sacs.ucsf.edu/TOPO2-run/wtopo2.pl 
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threonine and an asparagine at position 220 mutated to tyrosine also appeared. The most 
notable mutation, however, was a 192 base pair or 64 amino acid insert, here referred to as 
Ins64. This mutation showed only a 0.3 °C increase in aggregation temperature, but 
remarkably, the protein could still transport the antibiotic alafosfalin in the growth assay. 
 
Table 9. Increase of aggregation temperatures in different functional mutants. 
Mutant aggregation temperature 
∆ wildtype in °C 
comment 
L190V + 1.4/ + 3 found twice in thermostability screen, L-O-F 
T193A + 7.85  
T193I + 0.7  
I194N + 0.7  
K210T + 1.9  
N217K + 3.1  
N217S + 0.9  
N220Y + 1.4  
Ins 64 + 0.3 192 bp/64 amino acid insert 
 
 
To confirm that these mutants were indeed more thermostable, all nine mutant proteins 
were purified in a large-scale protein purification (see 2.2.3.2.). The proteins were then 
analysed in a Stargazer assay to determine the stability of the highly pure protein. 
Unfortunately, none of the candidate proteins were more thermostable, except for the 
insertion mutant Ins64 (Fig. 21). Mutants T193I, T194A and N220Y were within a 0.7 °C 
range compared to the wildtype. K210T and N217K were 1.2 and 1.4 °C lower, I194N and 
N217S 2.4 and 2.6 °C. The L190V mutant, which showed up two times in the 
thermostability screen, was even 4.5 °C decreased. The only mutant that was surprisingly 
more thermostable was the Ins64 mutant, which was 2°C higher than the wildtype. 
Unexpectedly, the aggregation temperatures were very concentration dependent, as can be 
seen in Figure 21, where the temperature difference between 0.1 mg/ml samples and 0.2 
mg/ml samples is shown. The aggregation temperature of the wildtype in its lower 
concentration is 9°C higher than the sample with the higher concentration. This feature had 
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not been observed in previous Stargazer experiments (see Results 3.1.3.). However, this 
explained the false positive thermostable mutants detected in the Stargazer assay since the 
concentrations in the high-throughput purified protein samples differed to a very large 
degree. Library helix 8/9 was not analysed for thermostability since it was already clear 
that the Stargazer assay is tremendously concentration dependent. 
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Figure 21. Aggregation temperatures of purified thermostable candidates. The diagram 
compares the aggregation temperature of different mutants in two different protein concentrations 
(blue: 0.1 mg/ml; purple: 0.2 mg/ml). None of the candidates is actually more thermostable than the 
wildtype except the insertion mutant Ins64. 
 
 
 
3.3. Optimization of the screen 
 
Since the aggregation temperature was found to be concentration dependent, this caused an 
immense problem for the thermostability screen because the concentrations in the high 
throughput purified protein samples varied greatly. Also, another major problem arose. The 
highly pure protein already has a quite high aggregation temperature. Since the Stargazer 
measures protein aggregation from 25°C to 80°C, proteins with aggregation temperatures 
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above 70°C do not give interpretable results. Additionally, the high throughput purified 
protein was further stabilized by the impurities abundant in the purification. This poses an 
additional problem for accuracy when wanting to observe minor temperature changes in 
the range of 2 to 3°C. In order to solve this problem, two strategies were developed. First, 
the concentration from the HTP purifications had to be determined much more accurately. 
However, since it would be too laborious an effort to bring 96 different samples to exactly 
the same concentration, a “standard curve” plotting temperature against concentration 
should be established so that the temperatures and concentrations obtained from the screen 
could be normalized to this standard curve. Second, the aggregation temperature of YdgR 
should be reduced, in order to obtain lower and therefore more accurate values of the 
Stargazer assayed HTP proteins. 
 
 
3.3.1. Concentration dependence of the Stargazer assay 
 
The concentration dependence had not been tested in the larger volume plates before the 
purified candidates with increased thermostability were assayed (see Results 3.1.3.). 
Thereafter, the aggregation temperature of purified wildtype protein in increasing 
concentrations from 0.05 mg/ml to 0.6 mg/ml was determined. As can be seen in Figure 
22, the aggregation temperature decreased with increasing protein concentrations. The 
curve is relatively linear from a concentration between 0.1 and 0.25 mg/ml and flattens out 
at higher concentrations. The data point at 0.05 mg/ml was not interpretable since the 
aggregation curve was distorted.  
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Figure 22. Concentration dependency of aggregation temperatures. The determined 
aggregation temperatures depend on the protein concentration of the Stargazer sample. The curve 
shows that the higher the concentration is, the lower the temperature. In a concentration range from 
0.1 mg/ml to 0.25 mg/ml the decrease seems to be linear. 
 
 
 
3.3.2. Determination of protein concentration 
 
As mentioned previously, the protein concentration in the HTP purifications had only been 
approximated to lie between 0.1 mg/ml and 0.2 mg/ml. This was done by measuring the 
absorbance at 280 nm of about 10 to 15 sample concentrations with the Nanodrop 
spectrophotometer, and analysing the whole 96 well plate in a Synergy plate reader (also at 
280 nm), calculating a standard curve, and calculating the other values from this curve. 
However, the values were very inaccurate when comparing the concentrations measured 
with the Nanodrop to calculated ones, but it was considered to be enough to give rise to 
interpretable Stargazer melting curves. Although measuring the absorbance at 260/280 nm 
is normally a very accurate method, this assay was not sensitive enough to obtain accurate 
concentrations in small volume samples. Many proteins assays are not compatible with 
certain buffer components, especially detergents and reducing agents. Three other assays 
were tested: the Lowry assay in microplates, which was not compatible with the high 
imidazole concentrations, and the Pierce assay 660 nm and the Pierce fluoraldehyde assay, 
both of which react with amino acids with measurable light absorbance. The latter turned 
out to be very accurate in the low concentration range of the HTP purifications. One 
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drawback, however, was that the reagent also reacted with the free amino groups of the 
Tris buffer. However, since HEPES worked for the purification as well, and more 
important, reduced the thermal stability (see below, 3.4.3.), it was decided that the 
purification be carried out in HEPES buffer instead of Tris. 
 
 
3.3.3. Decreasing the thermostability of the wildtype protein 
 
As already discussed, the thermostability of the HTP purified proteins should be decreased 
to yield more reliable aggregation temperatures. 90 mutants of library helix 8/9 were 
purified without glycerol to yield lower aggregation temperatures. In a Stargazer screen 
with protein purified under the original conditions, 10 % glycerol in the buffer enhances 
the stability by approximately 5.4 °C at a concentration of 0.1 mg/ml and 5.8 °C at 0.2 
mg/ml (Fig. 23). Also, DTT was beneficial for YdgR stability, and resulted in an increase 
of 5.1 °C or 3.7 °C, respectively (see bars for thermostability without glycerol, with and 
without DTT). Addition of 200 mM substrate alanyl-alanine increased protein stability 
greatly (+11.3 and 12.4 °C, respectively). Notably, the temperature difference between the 
0.1 and 0.2 mg/ml samples is not as pronounced as for the other conditions when substrate 
is present. 
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Figure 23. Stabilization and destabilization of YdgR. Upon addition of certain buffer 
components, the protein is stabilized. Alanyl-alanine, glycerol and DTT increase the thermal 
stability. 
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Purification without glycerol (no glycerol in the wash and elution buffers) reduced the 
temperature, but also resulted in low quality aggregation curves, and was therefore not 
optimal for the Stargazer assay. DTT had already been excluded from the HTP purification 
quite early in the optimization process. The buffer was then changed from Tris to HEPES, 
since lower aggregation temperatures had been observed in this buffer (experiment from 
Bettina Spitzenberger).  
 
 
3.3.4. HTP standard curve 
 
To be able to calculate enhancements in thermostability in the HTP assay, the “standard 
curve” was repeated with HTP purified YdgR in HEPES. The purification was performed 
using the standard GE Healthcare pre-pipetted Ni-plates as well as self-pipetted Qiagen Ni-
NTA. YdgR concentrations were determined by measuring at 260/280 nm in the 
Nanodrop, and protein samples from 0.05 to 0.55 mg/ml were analysed in a Stargazer 
assay. As in the curve from the pure protein (Fig. 22), the decrease in temperature is 
relatively linear at first, and flattens out at higher concentrations (Fig. 24). An expansion of 
the linear part of the curve can be seen in the lower part of Figure 24 with the respective 
trend-lines and equations. The protein purified from the self-pipetted plate seemed to have 
slightly higher thermostability, and also exhibits slightly higher purity than the protein 
purified over the commercially available Ni-NTA 96 well plates (data not shown). 
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Figure 24. High-throughput purification standard curve. Since the aggregation temperature is 
very much concentration dependent, thermal stability of HTP purified protein was determined, and 
plotted against its concentration. From this standard curve, which is linear in the initial range (see 
arrow, enlargement, see also Fig. 22), obtained values from future HTP purifications can be back-
calculated. 
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3.4. Characterization of loss-of-function mutants  
 
In the screens of libraries helix 6/7 and helix 8/9 twenty-three loss-of-function mutants 
with single amino acid substitutions were found. Reason for a loss of function could be a 
misfolded protein, incorrect localisation or a protein locked in a single conformation that 
has therefore lost its transport ability. However, the growth assay with alafosfalin does not 
rule out that the mutant proteins may still transport other substrates. In order to 
characterize these mutants further, I performed the experiments described below. 
 
3.4.1. Localisation to the plasma membrane 
 
3.4.1.1. Small-scale membrane preparation.  
First, proper localisation to the plasma membrane was verified by expressing the wildtype 
and mutant proteins in small scale cultures (see Materials and Methods, 2.2.3.1.), preparing 
membranes and analyzing them on a Western blot. With the help of Thomas Pollak, I 
could confirm that most of the mutant proteins with a single amino acid change were 
localized to the plasma membrane. In Figure 25A, cells expressing YdgR wildtype ( + 
control), the M154K and the A184T loss-of-function mutants before and after induction as 
well as purified membranes, and the supernatant yielded in the ultracentrifugation step are 
shown. There is sparse leaky expression of YdgR before induction, but it is greatly 
enhanced after induction with 0.1 mM IPTG and overnight expression at 18°C. Also, the 
negative control, i.e. cells harbouring the empty vector, displayed a weak background 
band. The protein signal (5 µg of protein) in the membranes is much stronger compared to 
the cells and the supernatant. However, because this Western is overexposed, one cannot 
compare the relative protein amount. However, it can be easily seen that there is little 
protein remaining in the cytosolic fraction (supernatant). The generation of additional 
inclusion bodies, however, cannot be excluded.  Figure 25B shows some examples of 5 µg 
of membranes analyzed on a Western Blot with a 1:20 dilution of ECL. All proteins except 
the A264P, R305C, and the L324V mutants were abundant in the membranes. Also, the 
Q320L mutant exhibited only a very weak signal when the blot was exposed longer. 
Whether these three proteins were not expressed properly or whether they remained in the 
cytoplasm as inclusion bodies remains to be tested.  
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Figure 25. Membrane expression of L-O-F mutants. The membrane expression of YdgR mutant 
proteins was confirmed on a Western blot. All mutants except four (A264P, R305C, L324V, 
Q320L) were positively expressed in the plasma membrane. 
 
 
3.4.1.2. GFP fluorescence 
One other possibility to verify proper membrane localisation is to label the recombinantly 
expressed protein with a GFP-tag. When a protein tagged with GFP is overexpressed in its 
correctly folded form, or in this case in the native membrane inserted state, the GFP is able 
to fold correctly and fluoresce. However, when the protein is accumulating in inclusion 
bodies and in an unfolded/aggregated state, GFP is not properly folded and hence does not 
fluoresce (Drew et al., 2001). The wildtype and 6 loss-of-function mutants (M154K, 
Y156A, A184T, L190V, N196K, F197I) were cloned with a C-terminal GFP-tag (see 
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Materials and Methods). All of the tested mutants showed GFP fluorescence (Fig. 26) and 
are therefore most probably inserted properly in the plasma membrane. Compared to the 
uninduced cells, the fluorescence signal approximately doubled except for the expressed 
GFP positive control. The soluble GFP is naturally expressed in the cytoplasm and at much 
higher levels than when attached to a membrane protein.  Cells expressing the positive 
control therefore showed an elevated level of fluorescence.  
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Figure 26. GFP-fluorescence of membrane expressed L-O-F mutants. GFP fusion protein 
variants were tested for GFP fluorescence. All of the so far tested mutants expressed GFP, and are 
therefore most likely properly folded in the membrane. These results also mirror the small-scale 
purifications (see Fig. 25) 
 
 
 
3.4.2. Transport assay 
 
As already mentioned, YdgR transports a vast number of substrates, not only di- and 
tripeptides, but also drugs and peptidomimetics such as the antibiotic alafosfalin used in 
the growth assay. Although the transporter is not very specific concerning its substrates, it 
is unlikely that it binds and transports all of its substrates with the same affinity or rate, 
respectively. The loss-of-function mutants discovered in the growth assay were identified 
as proteins that had lost the ability to transport alafosfalin. However, it would be possible 
that they are still able to transport other substrates.  In order to investigate this, I performed 
an in-vivo transport assay using AMCA-labeled alanyl-lysine. The label AMCA, N-7-
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amino-4-methylcoumarin-3-acetic acid, fluoresces upon excitation at 360 nm and the 
uptake of the dipeptide into the cells can be measured.  
The wildtype YdgR and the loss-of-function mutants Y156A, L190V, and N196K were 
tested in this transport assay. Additionally, the insertion mutant Ins64, which was able to 
transport alafosfalin, was also examined. Compared to the cells transformed with empty 
vector, the cells expressing wildtype YdgR transport about twice as much substrate. The 
transport activity of the control is most probably due to the natively expressed YdgR and to 
residual traces of dye that have not been washed away. The number of cells should be the 
same for every construct tested. However, it must also to be taken into account that not 
every mutant is expressed at the same level, and that some of the cells measured by 
absorbance at 600 nm might be dead. For this reason, a dilution series of the applied cells 
was carried out to determine the number of live cells by counting the number of colony 
forming units. The number of live cells was relatively even among the mutants, while the 
wildtype and vector samples contained four to five times more live cells (empty vector: 
7*108 cells, wildtype: 5.8*108 cells, Y156A: 2.5*108 cells, L190V: 1.4*108 cells, N196K: 
1.6*108 cells, Ins64: 1.3*108 cells). A Western blot comparing protein levels was also 
carried out as a control (Fig. 27B). The quality of the Western blot is relatively poor 
because the signal was much too strong, and the blot could only be photocopied after 
incubation with the ECL reaction kit instead of developing it. However, it can be easily 
seen that there is no protein in the vector control and that the wildtype, Y156A and L190V 
protein levels are relatively even. The N196K mutant exhibits a slightly weaker band, and 
the Ins64 mutant displays less than half the protein concentration when compared to the 
wildtype.  When comparing these results to the results of the uptake assay (Fig. 27A), it 
can be concluded that the mutants Y156A and N196K actually are loss-of-function 
mutants, whereas the L190V could still transport the AMCA labeled dipeptide. The 
insertion mutant Ins64 also showed very low uptake levels, but may still be a functional 
transporter since only half as much protein is expressed when compared to the wildtype. 
The assay definitely requires optimization since the errors are too broad with the frequent 
occurrence of outliers, and there seems to be residual fluorescence that is not due to the 
uptake by YdgR, but rather to AMCA-labeled substrate retained on the filter-plates used in 
this assay. 
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Figure 27. In-vivo transport assay. AMCA-labeled alanyl-lysine is a substrate for YdgR. (A) 
The diagram shows the transport functions of wildtype and several mutants i.e. the buffer control 
(blue) and the uptake of AMCA-Ala-Lys (purple). The L-O-F mutants Y156A and N196K did 
indeed lose their ability to transport. L190V was defective or the uptake of alafosfalin, but could 
still transport the dipeptide. Ins64 could still transport AMCA-Ala-Lys, what can only be seen 
when (B) comparing protein expression levels of the different constructs. 
 
 
 
3.4.3. Thermostability of loss-of-function mutants. 
 
Since the loss-of-function mutants have lost their ability to transport, it would be possible 
that some of these mutant proteins are trapped in a certain conformation. A mutant protein 
that is less flexible or cannot transition from one state to another, i.e. from the open to the 
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closed state, for example, might be also more thermostable than the wildtype protein. One 
of the loss-of-function mutants, L190V, was defective in alafosfalin, but not in β-Ala-Lys-
AMCA uptake. Its thermostability has already been determined with the other thermostable 
candidates (see Results 3.2.3.), and it was approximately 3°C lower than the wildtype.  
Four other loss-of-function mutants (M154K, A184T, N196K, F197I), the wildtype protein 
and Ins64 as a positive control were purified over Ni-NTA (without gel filtration) and 
thermostability was measured in a Stargazer experiment. All the different mutants were 
purified at the same time, and thermostability was measured with freshly purified protein 
(Fig. 28). As in previous experiments, the aggregation temperature of the Y156A mutant 
was decreased. The positive control Ins64, which was already identified as a thermostable 
variant, showed an increase of 9.5°C (0.1 mg/ml) and 13.4°C (0.2 mg/ml), respectively. 
Remarkably, three mutants, namely M154K (+3.5°C), N196K (+3.9°C) and F197I 
(+4.3°C) exhibited enhanced thermostability, the latter two also at 0.2 mg/ml (N196K: 
+2.1°C, F197I: +0.4°C). Also, the temperature of the A184T mutant was slightly increased 
(+1.3 and +0.95, respectively). 
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Figure 28. Aggregation temperatures of purified L-O-F mutants. The diagram compares the 
aggregation temperature of several purified loss-of-function mutants in two different protein 
concentrations. Indeed, three of the mutants, M154K, N196K and F197I exhibit an elevated 
thermal stability when compared to the wildtype. Ins64 served as a positive control. 
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The aggregation temperatures of all mutants, except for the insertion Ins64, increased 
enormously upon addition of substrate, either 200 mM alanyl-alanine or 100 mM 
alafosfalin (Fig. 29). This stabilizing effect is most probably due to binding of the substrate 
to the transporter. Ins64 could transport both alafosfalin and alanyl-lysine-AMCA, but it 
seemed that the addition of substrate does not stabilize this mutant protein. In this case, 
substrate binding may be very weak. 
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Figure 29. Stabilizing effects of substrate addition. Upon addition of 200 mM Ala-Ala or 100 
mM alafosfalin, wildtype YdgR is remarkably stabilized. This is also true for most of the mutants 
except for the insertion mutant Ins64. 
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4. Discussion 
 
 
 
In this diploma project, a simple and efficient screen to identify thermostable mutants of 
the Escherichia coli dipeptide transporter YdgR was developed and optimized. In 
summary, the screen consists of two steps. First, a growth assay distinguishes between 
active transporters and loss-of function mutants. In a second step, these proteins are first 
high-throughput purified and then subjected to a thermostability assay.  
The initial screen yielded eight mutant candidates that were suspected to be more 
thermostable than the wildtype. However, after purifying them to high purity, and assaying 
them with the Stargazer thermostability assay, they proved to be false positives. Only one 
of the candidate proteins actually possessed a higher thermal stability than the wildtype. 
This one exception was a protein with a 192 bp insertion (64 amino acids) that coded for 
the predicted helices 6 and 7. Therefore, it is possible that this mutant protein contains two 
additional transmembrane helices. It is not clear why a larger protein with even more 
hydrophobic regions should be more thermostable. On the other hand, these helices might 
be stabilizing each other, resulting in a less flexible and therefore more stable structure. 
However, the insertion mutant is not useful for structure determination by X-ray 
crystallography because the insertion probably alters the overall protein architecture. 
However, it was later used as a positive control. The high number of false positives, and 
probably also false negatives, was due to the tremendous concentration dependency of the 
Stargazer thermostability assay. Furthermore, the high aggregation temperatures of the 
HTP purified proteins impeded interpretable results. In order to solve these problems, two 
strategies were developed. First, a standard curve plotting the aggregation temperatures 
against the protein concentration was established, in order to be able to normalize the 
aggregation temperatures obtained in the screen to this standard curve. Second, the overall 
aggregation temperature was reduced by altering buffer components, and also the purity of 
the HTP purified protein was increased. These strategies should now greatly reduce the 
numbers of false positives and negatives, and lead hopefully to the discovery of 
thermostable active transporters. 
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A second major part of this diploma thesis was to identify and characterize YdgR loss-of-
function mutants. The screen yielded 23 loss-of-function mutant proteins with a single 
mutation that lost the ability to transport the YdgR specific antibiotic alafosfalin. All of 
these mutants except three were determined to be properly expressed in the membrane, 
several also in a GFP fluorescence assay to verify proper membrane insertion. The GFP-
fluorescence assay might be a rather quick alternative to small-scale membrane preparation 
and Western blotting. However, the assay remains to be optimized and tested with negative 
controls that do not insert into the plasma membrane. Furthermore, an in-vivo transport 
assay should provide insights into the specificity and transport abilities of the various 
mutant proteins. However, the transport assay used here has to be optimized in order to 
obtain reliable and reproducible results.  
As already mentioned in the introduction, two membrane proteins, namely the β-adrenergic 
receptor 1 (Serrano-Vega et al., 2008) and the lactose permease LacY (Abramson et al., 
2003) have been crystallized as protein variants with enhanced thermal stability. The β-AR 
was subjected to alanine scanning and a combination of six point mutations lead to an 
increase in thermostability of 21°C. LacY contained only a single point mutation that 
rendered the protein more thermostable, a cysteine to glycine substitution. Both methods 
bear immense disadvantages compared to the method applied in this project. First, the 
generation of mutants for the β-AR was very labour intensive since every amino acid had 
to be mutated to an alanine using site-directed mutagenesis. In my project, a random 
mutant library was generated. This guarantees a mutation of every amino acid targeted in 
the random mutagenesis if the library is large enough to statistically cover all of them. 
Also, the library does not only contain mutations to alanine but to all other essential amino 
acids. Serrano-Vega et al. showed that mutations to other amino acids than alanine 
rendered the proteins usually not more thermostable than the alanine itself. Nevertheless, 
this might not be true for other proteins. LacY contains eight cysteines, each of which was 
mutated to create a LacY mutant devoid of cysteines. The increase in thermostability of the 
C154G mutation was rather a coincidental side-effect. Therefore, it would be impossible to 
predict such an effect of a cysteine mutation in a different protein. 
 
An enormous advantage of the introduced screening method is also that the assay 
determining the thermal stability is not dependent on any enzymatic activity. This makes 
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the method broadly applicable to other proteins. Determining the thermostability of an 
enzyme is often rather easy since a certain enzymatic activity can be measured. 
Transporters, however, often lack an enzymatic activity. In the case of the β-AR, the 
increase in thermostability was determined by a radioligand binding assay. The protein was 
purified over Ni-IMAC, and 20 – 100 µg of protein were used in the binding assay. Non-
bound radioligand had to be removed via a gel filtration step. Again, this is a very time-
consuming and laborious assay. Similarly, the thermostability of the LacY mutant was 
determined measuring substrate binding to wildtype and mutant protein after heating. Also 
here, relatively high concentrations (120 -140 µM) of highly pure protein (90-95 %) were 
needed to perform these assays. The determination of the thermal stability in a Stargazer 
assay is therefore highly advantageous. First, only 5 -10 µg of each HTP purified protein is 
necessary to perform the Stargazer assay. Second, the assay is easy and fast, and no 
radioactive substrate is needed. 
As also mentioned in the introduction, transporter proteins are rather flexible. The cysteine 
LacY mutant was shown to be locked in a certain conformation (Smirnova et al., 2003) 
since it can still bind to substrate but cannot translocate it across the membrane. Here, six 
YdgR loss-of-function mutants were assayed for their thermostability. Two of them, 
N196K and F197I, indeed exhibited a higher aggregation temperature than the wildtype 
protein. The mutations evidently lie directly beside each other, strongly indicating that they 
actually render YdgR more thermostable. Also, another mutant, M154K, showed a slight 
increase in aggregation temperature, but only at 0.1 mg/ml Stargazer sample concentration. 
The first two are good potential candidates, which should now be further characterized and 
eventually used for crystallization trials. Also, these mutations should be combined in 
order to test for further enhancement of the aggregation temperature. These residues could 
also be mutated to alanines, since Serrano-Vega et al. found mutations to alanine to be the 
most stabilizing. Most important, 17 loss-of-function mutants remain to be tested for their 
thermostability. Furthermore, the screening of YdgR should be continued in order to find 
more thermostable candidates and interesting loss-of-function mutants. 
In summary, this screening method provides a number of advantages. It neither relies on 
enzymatic activity nor on the presence of certain amino acid residues in the protein. The 
assays are rapid and easy, also when compared to the other two described methods. 
Furthermore, the functionality of the transporter is determined in the first step, the growth 
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assay, and identified loss-of-function mutants give insights into the significance of 
particular residues or amino acid stretches. More important, this screen should be broadly 
applicable to other proteins, and could be a very useful method to increase the number of 
solved membrane protein structures. 
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